{"study_id": 31907, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of piperine as a treatment for PCOS by analyzing its binding interactions with key molecular targets implicated in PCOS pathogenesis.", "results_summary": "The study found favorable binding affinities between piperine and key PCOS-related genes (PPARG and H6PD), suggesting its potential to modulate these targets. Molecular simulations supported the reliability of these interactions, indicating piperine's therapeutic promise for PCOS.", "population_specificity": "Women with PCOS (computational study, no human subjects).", "effective_dosage": "Not available", "study_duration": "Not applicable (computational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:14.818430+00:00"}
{"study_id": 31914, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate whether piperine (PIP) could enhance the sensitivity of triple-negative breast cancer (TNBC) cells to doxorubicin (DOX) by targeting the PI3K/Akt/mTOR pathway and cancer stem cells (CSCs).", "results_summary": "The study found that PIP synergistically enhanced DOX's effect on TNBC cells, suppressing the PI3K/Akt/mTOR pathway and reducing CSC markers like ALDH-1. In vivo results showed increased tumor necrosis and downregulation of key resistance-related proteins, suggesting PIP may reduce DOX resistance.", "population_specificity": "Triple-negative breast cancer (MDA-MB-231 cell line) and Ehrlich ascites carcinoma solid tumor model in animals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:15.821126+00:00"}
{"study_id": 31917, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of piperine, alone and combined with aerobic exercise, against paraquat-induced lung damage in rats.", "results_summary": "Piperine significantly reduced oxidative stress, inflammation, and histopathological damage in lung tissue, with stronger effects when combined with exercise training compared to exercise alone. The combination of piperine and exercise showed comparable or superior protective effects to vitamin E, a positive control.", "population_specificity": "Male Wistar rats (230 g, 6-8 weeks old)", "effective_dosage": "10 mg/kg/day (orally)", "study_duration": "7 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:18.509144+00:00"}
{"study_id": 31916, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether piperine, when combined with curcumin, could improve oxidative stress markers, fecal calprotectin, and pro-inflammatory cytokines in patients with inflammatory bowel disease (IBD).", "results_summary": "The study found that curcumin plus piperine significantly increased serum superoxide dismutase (SOD) levels compared to placebo, but no significant differences were observed in fecal calprotectin, inflammatory markers, or other oxidative stress indicators.", "population_specificity": "Adults (\u226518 years) with Crohn's disease or ulcerative colitis and intact liver/kidney function.", "effective_dosage": "10 mg/day of piperine combined with 1000 mg/day of curcumin.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:18.644709+00:00"}
{"study_id": 31918, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a stable piperine-loaded nanoemulsion to enhance its solubility and evaluate its antifungal efficacy against Candida spp. compared to pure piperine in DMSO.", "results_summary": "The study found that the piperine-loaded nanoemulsion had significantly enhanced antifungal activity, with MIC90 values 20-50% lower than pure piperine in DMSO, and demonstrated stability with no observable physical changes. The nanoemulsion showed consistent efficacy across all tested Candida spp.", "population_specificity": "Candida spp. (including C. albicans and C. glabrata) in vitro.", "effective_dosage": "0.8-2.0 mg/mL (MIC90 range).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:19.753307+00:00"}
{"study_id": 31919, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if co-loading Piperine (PIP) with Resveratrol (RSV) in phytosomes enhances pharmacokinetic properties and cardioprotective effects in myocardial infarction (MI).", "results_summary": "The study found that RSV phytosomes co-loaded with PIP (RPP) significantly improved heart rate, ECG, biomarker levels, and antioxidant activity in MI-induced rats, with prolonged systemic circulation (>24h) compared to free drugs.", "population_specificity": "Isoproterenol-induced myocardial infarction rats and healthy Wistar rats.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:20.387079+00:00"}
{"study_id": 31920, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate Piperine's effects on ARL3 expression, cell proliferation, EMT, and ER stress in colorectal adenocarcinoma (COAD) cells.", "results_summary": "Piperine inhibited COAD cell proliferation, induced apoptosis, downregulated ARL3 expression, suppressed EMT, and attenuated ER stress responses. These effects suggest Piperine has anti-cancer potential in COAD.", "population_specificity": "Colorectal adenocarcinoma (COAD) cells in vitro.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:20.475749+00:00"}
{"study_id": 31921, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to elucidate the molecular mechanisms of piperine's antitumor effects in colorectal cancer (CRC) cells, focusing on autophagy, ROS accumulation, and AKT/mTOR pathway inhibition.", "results_summary": "Piperine inhibited CRC cell viability and tumor growth in a mouse model by inducing autophagy-dependent cell death, increasing ROS production, and suppressing AKT/mTOR signaling. Activation of AKT or ROS clearance attenuated these effects.", "population_specificity": "Human colorectal cancer cells (in vitro) and a xenograft tumor mouse model using CT26 cells (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:22.141192+00:00"}
{"study_id": 31923, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antimicrobial, antioxidant, and anticancer properties of piperine-coated zinc oxide nanoparticles (ZnO-PIP NPs) against dental pathogens and oral cancer cells.", "results_summary": "ZnO-PIP NPs demonstrated significant antioxidant activity, strong antimicrobial effects (MIC of 50 \u00b5g/mL), and dose-dependent anticancer activity on KB oral squamous carcinoma cells, upregulating apoptotic genes.", "population_specificity": "Dental pathogens and KB oral squamous carcinoma cells (in vitro study).", "effective_dosage": "MIC of 50 \u00b5g/mL (antimicrobial testing); anticancer testing was dose-dependent but specific dosages not detailed.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:25.097297+00:00"}
{"study_id": 31922, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effects of a curcumin-piperine combination on cyclophosphamide-induced brain damage in rats by measuring biochemical and histopathological parameters.", "results_summary": "The study found that the curcumin-piperine combination reduced oxidative stress and inflammatory markers (8-OHdG, NO, IL-6, NF-k\u03b2, MDA, TNF-\u03b1) and increased antioxidant levels (SOD, CAT, GPx, GSH) in CP-treated rats, but did not significantly affect pTAU, A\u03b21-42, GLU, or GABA levels.", "population_specificity": "Rats treated with cyclophosphamide (CP) to induce brain damage.", "effective_dosage": "200 or 300 mg/kg CUR-PP via oral gavage.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:25.146555+00:00"}
{"study_id": 31925, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether piperine enhances the sensitivity of prostate cancer cells to docetaxel (DTX) and elucidate its mechanism of action, particularly focusing on the Notch signaling pathway.", "results_summary": "Piperine reduced cell viability, induced apoptosis, and inhibited migration and invasion in both DTX-sensitive and DTX-resistant prostate cancer cells. It also downregulated the Notch signaling pathway by inhibiting Notch1 and Jagged1 and reducing downstream effector expression.", "population_specificity": "DTX-resistant prostate cancer cell line (DU145/DTX) and its DTX-sensitive counterpart (DU145).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:28.466193+00:00"}
{"study_id": 31924, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of curcumin-piperine supplementation on inflammatory markers, antioxidant capacity, and clinical outcomes in patients who underwent CABG surgery.", "results_summary": "The study found that curcumin-piperine significantly reduced CRP levels and increased TAC, with marginal reductions in CK-MB, but no significant effects on troponin I, LDH, ejection fraction, or arterial fibrillation.", "population_specificity": "Adults who underwent CABG surgery (n=80).", "effective_dosage": "500 mg curcumin + 5 mg piperine per tablet, administered as 1-3 tablets daily (5-15 mg piperine/day).", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:28.512941+00:00"}
{"study_id": 31926, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of curcumin and piperine supplementation on glycemic parameters (FPG, HOMA-IR, BMI) in patients with prediabetes and type 2 diabetes.", "results_summary": "The study found mixed results, with two studies showing no significant difference in outcomes between the supplement and placebo groups, while one study reported a significant reduction in BMI. Meta-analysis indicated numerical but non-significant improvements in FPG, HOMA-IR, and BMI.", "population_specificity": "Patients with prediabetes and type 2 diabetes mellitus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:28.911128+00:00"}
{"study_id": 31928, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether adding piperine to a curcumin patch enhances its analgesic effects in managing acute postoperative orofacial pain.", "results_summary": "The study found no significant additional benefit from piperine when combined with curcumin patches compared to curcumin alone, though within-group comparisons showed some pain reduction. Salivary PGE2 levels indicated differences between piperine and non-piperine groups, but overall group comparisons were not statistically significant.", "population_specificity": "75 patients who underwent oromaxillofacial surgery at Unpad Dental Hospital, Bandung, Indonesia.", "effective_dosage": "Not specified", "study_duration": "Evaluated at two time points eight hours apart.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:30.674398+00:00"}
{"study_id": 31929, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness of piperine in combination with curcumin and taurine as an adjuvant therapy to enhance immune response and improve clinical outcomes in HCC patients treated with TACE.", "results_summary": "The study found that the combination therapy significantly increased serum IFN-\u03b3 levels, downregulated PD-1 expression in MNLs, and reduced CD4+CD25+ regulatory T lymphocytes, alongside improvements in AST, LDH, and AFP levels.", "population_specificity": "20 TACE-treated hepatocellular carcinoma (HCC) patients.", "effective_dosage": "10 mg piperine daily.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:30.819245+00:00"}
{"study_id": 31927, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of curcuminoids (with piperine) on oxidative stress and antioxidant capacity in girls with premenstrual syndrome (PMS) and dysmenorrhea.", "results_summary": "The study found that curcuminoids (with piperine) significantly increased free-radical scavenging activity in serum compared to placebo, but no significant changes were observed in other oxidative stress markers. The results suggest potential antioxidant benefits, though higher doses and longer durations may be needed for clearer effects.", "population_specificity": "Young girls with both PMS and dysmenorrhea (n=80).", "effective_dosage": "500 mg curcuminoids + 5 mg piperine daily.", "study_duration": "7 days pre- until 3 days post-menstrual bleeding for 3 successive cycles.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:31.380416+00:00"}
{"study_id": 31930, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of piperine on muscle force production, its reversibility, and potential mechanisms, including Ca2+ sensitivity.", "results_summary": "Piperine increased low-frequency force in both slow- and fast-twitch muscle, was reversible, and partially recovered force in fatigued muscle. The primary mechanism was an increase in Ca2+ sensitivity without affecting intracellular Ca2+ levels.", "population_specificity": "Rats and mice (isolated muscles and single fibres)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:32.829928+00:00"}
{"study_id": 31932, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the bioavailability of a natural turmeric extract (WDTE60N) with a reference product containing curcuminoids and piperine (CPC).", "results_summary": "The test formulation WDTE60N demonstrated improved relative absorption and equivalent exposure at a 10-fold-lower dose of actives compared to the reference CPC, which contained piperine. Piperine was used in the reference product to enhance bioavailability, but the study did not isolate its individual effects.", "population_specificity": "Sixteen healthy adult male subjects.", "effective_dosage": "Reference product CPC contained 500 mg curcuminoids and 5 mg piperine, administered 3 times daily (total 15 mg piperine/day).", "study_duration": "Single-day dosing with blood sampling over 24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:34.837951+00:00"}
{"study_id": 31933, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the molecular mechanism of a 308-nm excimer laser combined with piperine in regulating melanocyte proliferation, migration, and melanin production for vitiligo treatment.", "results_summary": "The combination of the 308-nm excimer laser and piperine enhanced melanocyte proliferation, migration, and melanin production, upregulated miR-328, and inhibited SFRP1, activating the Wnt/\u03b2-catenin pathway. Restraint of miR-328 reversed these effects.", "population_specificity": "Epidermal melanocytes in vitro", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:37.607153+00:00"}
{"study_id": 31935, "supplement_id": 1452, "safety_score": "80", "efficacy_score": 67, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the leishmanicidal activity and safety of piperine (PIP) as a potential topical treatment for cutaneous leishmaniasis caused by L. braziliensis.", "results_summary": "Piperine showed high in vitro leishmanicidal activity at 8 mM and no cytotoxicity for U937 macrophages. In vivo, topical PIP treatment cured 67% of infected hamsters, demonstrating moderate efficacy compared to quercetin (100%) and curcumin (83%).", "population_specificity": "Golden hamsters infected with stationary-phase L. braziliensis promastigotes.", "effective_dosage": "Not specified (in vitro: 8 mM; in vivo: concentration not detailed).", "study_duration": "15 days (in vivo).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:38.425452+00:00"}
{"study_id": 31938, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-prostate cancer (PCa) effects of piperine, particularly its ability to inhibit AKT1 activity, DNA damage, and colony formation in PC3 cells compared to SDF.", "results_summary": "Piperine significantly inhibited colony formation and caused DNA damage in PC3 cells, demonstrating stronger effects than SDF. Molecular dynamics simulations indicated stable binding of piperine to AKT1, suggesting potential for inhibiting PCa cell proliferation.", "population_specificity": "Human prostate cancer cell line PC3 (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:39.449187+00:00"}
{"study_id": 31936, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the biological activity of Piperine-loaded chitosan lipid nanoparticles (PP-CLNPs) alone or combined with Metformin for managing cognitive deficits in diabetic rats.", "results_summary": "PP-CLNPs showed high entrapment efficiency, enhanced in vitro release, and improved cognitive function while reducing oxidative stress in diabetic rats. Piperine also acted as a bio-enhancer, increasing Metformin's potency in protecting brain tissue from neuroinflammation and memory deterioration.", "population_specificity": "Diabetic rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Enhanced the potency of Metformin", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:39.519148+00:00"}
{"study_id": 31934, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine if combining Piperine (PIP) with Sorafenib (SORA) in PLGA nanoparticles could improve efficacy outcomes in hepatocellular carcinoma (HCC) treatment.", "results_summary": "The study found that PIP and SORA co-loaded into PLGA nanoparticles exhibited sustained drug release, high encapsulation efficiency, and superior cytotoxicity against HepG2 cells compared to SORA monotherapy. The formulation showed potential as an effective strategy for HCC treatment.", "population_specificity": "In vitro study using HepG2 hepatocellular carcinoma cells.", "effective_dosage": "Not specified (drugs co-loaded into nanoparticles with 0.5% PVA).", "study_duration": "Not specified.", "interactions": "Improved pharmacokinetic profiles of Sorafenib when combined with Piperine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:39.594230+00:00"}
{"study_id": 31937, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Piperine in NASH progression and identify its potential mechanisms, particularly focusing on hepatocyte pyroptosis and NF-\u03baB inhibition.", "results_summary": "Piperine alleviated liver steatosis, inflammation, hepatocyte injury, and fibrosis in mice fed with MCD diets. It also reduced pyroptosis markers (NLRP3, ASC, caspase-1 p20, GSDMD), IL-1\u03b2, and LDH release, with NF-\u03baB activation suppression playing a key role.", "population_specificity": "Mice with methionine- and choline-deficient (MCD) diet-induced NASH.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:40.074315+00:00"}
{"study_id": 31939, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Piperine (PIP) could protect against cyclophosphamide (CP)-induced testicular toxicity in mice by examining its antioxidant, antiapoptotic, and anti-inflammatory effects.", "results_summary": "PIP treatment reduced CP-induced testicular toxicity, improving sperm count, motility, and viability, while also mitigating oxidative stress, apoptosis, and histopathological damage. The protective effects were dose-dependent, with higher doses (10 mg/kg) showing more pronounced benefits.", "population_specificity": "Adult male BALB/c mice (30-35 g)", "effective_dosage": "5 mg/kg and 10 mg/kg of PIP", "study_duration": "8 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:41.664831+00:00"}
{"study_id": 31940, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effects of piperine on hyperuricemic nephropathy (HN) in mice and renal tubular epithelial cells, focusing on its antioxidant, anti-inflammatory, and uric acid-lowering properties.", "results_summary": "Piperine significantly reduced serum uric acid levels, improved kidney function in HN mice, and alleviated uric acid-induced damage in renal cells. It also inhibited transporter expression and activity, regulating the AKT/mTOR pathway both in vivo and in vitro.", "population_specificity": "Adenine and potassium oxonate-induced HN mice and uric acid-injured renal tubular epithelial cells (mRTECs).", "effective_dosage": "5 \u03bcM (in vitro)", "study_duration": "3 weeks (in vivo)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:45.043899+00:00"}
{"study_id": 31942, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of piperine on gut microbiota composition and diversity in the context of arsenic exposure using a mouse model.", "results_summary": "The study found shifts in microbial composition and abundance among intervention groups, suggesting piperine may influence gut microbiota diversity when co-administered with arsenic. However, specific taxa contributing to these changes were not detailed.", "population_specificity": "Mouse model (cecal samples from intervention groups: arsenic exposure, arsenic + piperine, piperine alone, and control).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:46.976189+00:00"}
{"study_id": 31941, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the role of piperine in hepatic ischemia/reperfusion injury (HIRI) and its underlying mechanisms.", "results_summary": "Piperine pretreatment improved liver function, reduced oxidative stress, decreased inflammatory cell infiltration, and attenuated TNF-\u03b1 and IL-6 production by inhibiting the TLR4/IRAK1/NF-\u03baB signaling pathway.", "population_specificity": "Mice subjected to hepatic ischemia-reperfusion injury.", "effective_dosage": "30 mg/kg, intragastric administration before surgery.", "study_duration": "Pretreatment before surgery, with evaluation after 24 hours of ischemia-reperfusion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:47.001720+00:00"}
{"study_id": 31944, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the clinical and RCM features of re-pigmentation in localized vitiligo using a combination of NB-UVB and piperine-based topical treatment.", "results_summary": "The study found that the combined treatment led to macules being \"slightly less noticeable\" with 25-50% re-pigmentation, along with significant improvements in irregular honeycomb patterns, non-pigmented papillae, dendritic cells, and blood vessels.", "population_specificity": "Eight patients with localized vitiligo enrolled at a single center.", "effective_dosage": "Topical treatment applied twice daily + NB-UVB twice weekly.", "study_duration": "2 \u00d7 2-month periods (total 4 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:49.161546+00:00"}
{"study_id": 31943, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of piperine on blood glucose and insulin levels by modulating hepatic HNF-1\u03b1 and SREBP-1c expression in T2DM rats and human Chang liver cells, comparing it to metformin.", "results_summary": "Piperine significantly reduced blood glucose and insulin levels in T2DM rats, upregulated HNF-1\u03b1 mRNA, and downregulated SREBP-1c mRNA, with effects comparable to metformin. In vitro studies confirmed similar gene expression changes in Chang liver cells.", "population_specificity": "Adult male albino rats with HFD and sucrose-induced T2DM, and human Chang liver cells.", "effective_dosage": "40 mg (rats)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:49.233843+00:00"}
{"study_id": 31946, "supplement_id": 1452, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic potential of piperine, including its bioactive effects, physiological benefits, and role in enhancing drug bioavailability.", "results_summary": "The study found that piperine exhibits multiple bioactive effects, including antibacterial, immunomodulatory, hepatoprotective, antioxidant, antimetastatic, and anticancer properties. Clinical trials highlighted its exceptional antioxidant, anticancer, and drug availability-enhancing capabilities, as well as immunomodulatory potential.", "population_specificity": "Not specified (general human health context).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Enhances bioavailability of other therapeutic medications, including chemotherapy drugs.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:49.405245+00:00"}
{"study_id": 31945, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antifungal and antibiofilm activity of piperine against Candida albicans, both alone and in combination with conventional antifungals.", "results_summary": "Piperine demonstrated antibiofilm activity with MBIC and MBEC ranging from 64 to 1024 \u03bcg/mL and 256 to 2048 \u03bcg/mL, respectively. It showed synergistic effects when combined with antifungals, particularly azoles, outperforming curcumin in synergy.", "population_specificity": "Multiresistant clinical isolates of Candida albicans.", "effective_dosage": "64 to 2048 \u03bcg/mL (concentration range tested).", "study_duration": "Not specified.", "interactions": "Synergistic effects noted with azoles and polyenes.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:49.505024+00:00"}
{"study_id": 31949, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the impact of piperine consumption on patients with NAFLD and early cirrhosis compared to placebo over 12 weeks.", "results_summary": "Piperine at 5 mg daily significantly reduced hepatic enzymes, glucose levels, and dyslipidemia, and improved HOMA levels and insulin resistance in NAFLD patients compared to placebo.", "population_specificity": "Patients with NAFLD and early-stage cirrhosis.", "effective_dosage": "5 mg daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:52.553399+00:00"}
{"study_id": 31947, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether colon-targeted piperine-glycyrrhizic acid nanocrystals (ES100-PIP/GA NCs) could effectively treat ulcerative colitis by modulating macrophage activity and reducing inflammation.", "results_summary": "The study found that ES100-PIP/GA NCs exhibited high drug loading and colon-specific release, effectively downregulated pro-inflammatory factors (IL-1\u03b2, IL-17A), upregulated anti-inflammatory factors (TGF-\u03b21), repaired the intestinal mucosal barrier, and significantly inhibited colitis in a murine model. The nanocrystals also enhanced M2 macrophages and inhibited M1 macrophages through mTOR and HIF-1\u03b1 regulation.", "population_specificity": "Murine model (mice with dextran sodium sulfate-induced acute colitis) and in vitro studies using RAW 264.7 and Caco-2 cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:53.165232+00:00"}
{"study_id": 31950, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether piperine (PIP) could improve the quality of porcine oocytes during in vitro maturation by reducing oxidative stress and enhancing subsequent embryo development.", "results_summary": "The study found that 200 \u03bcM PIP significantly improved blastocyst formation, reduced apoptosis, decreased reactive oxygen species, increased glutathione levels, and enhanced antioxidant and developmental gene expression in porcine oocytes. These benefits also translated to improved embryo development following somatic cell nuclear transfer.", "population_specificity": "Porcine oocytes", "effective_dosage": "50, 100, 200, or 400 \u03bcM PIP", "study_duration": "Duration of in vitro maturation (exact time not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:56.170897+00:00"}
{"study_id": 31955, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the therapeutic effects of piperine on the HL-60 cell line, focusing on its role in apoptosis and modulation of microRNAs and gene expression in AML.", "results_summary": "Piperine increased HL-60 cell viability and significantly upregulated miR-181a and c-Kit expression while also increasing BAX expression, suggesting potential anticancer effects. However, its impact on cell viability was mixed compared to other compounds tested.", "population_specificity": "HL-60 cell line (in vitro) and 150 newly diagnosed AML patients (for miR analysis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:58.164938+00:00"}
{"study_id": 31951, "supplement_id": 1452, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate Piperine's inhibitory mechanism on P-glycoprotein (P-gp) and its ability to enhance the sensitivity of paclitaxel (PTX) in treating triple-negative breast cancer (TNBC), as well as the safety and efficacy of albumin nanoparticles co-encapsulating PTX and PIP (PP@AN).", "results_summary": "Piperine enhanced intracellular PTX accumulation, increased cell sensitivity to PTX, and inhibited P-gp by competing with PTX binding, downregulating MDR1 gene and P-gp expression. PP@AN improved drug accumulation, downregulated P-gp in tumors, and reduced toxicity while enhancing antitumor effects in vivo.", "population_specificity": "Triple-negative breast cancer (TNBC) models (in vitro and in vivo).", "effective_dosage": "Optimal ratio PTX:PIP = 1:2 (specific amounts not detailed).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:58.414851+00:00"}
{"study_id": 31952, "supplement_id": 1452, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-Candida activity of piperine, its mechanisms of action, and its impact on virulence factors in Candida albicans.", "results_summary": "Piperine suppressed hyphal transition, hindered biofilm formation, disrupted cell membrane permeability and mitochondrial membrane potential, and induced reactive oxygen species accumulation in C. albicans. It also showed synergy with fluconazole against fluconazole-sensitive strains and demonstrated low cytotoxicity at low concentrations.", "population_specificity": "Fluconazole-sensitive and fluconazole-resistant Candida albicans strains.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:58.445751+00:00"}
{"study_id": 31954, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of a curcumin-piperine combination on inflammatory markers, lipid profiles, and other health indicators in patients recovering from ischemic stroke.", "results_summary": "The curcumin-piperine combination significantly reduced hs-CRP, total cholesterol, triglycerides, CIMT, weight, waist circumference, and blood pressure while increasing total antioxidant capacity. Pain scores increased less in the intervention group compared to placebo, but no significant changes were observed in fibrinogen, LDL, HDL, or quality of life.", "population_specificity": "Patients with ischemic stroke in the rehabilitation stage (mean age 59.80 \u00b1 4.25 years).", "effective_dosage": "500 mg curcumin + 5 mg piperine per tablet (frequency not specified).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:59.192362+00:00"}
{"study_id": 31957, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the formulation and effectiveness of PPN-encapsulated PCL nanoparticles (PPN-PCL-NPs) for improving the therapeutic efficacy of Piperine in breast cancer treatment.", "results_summary": "The optimized PPN-PCL-NPs demonstrated stable pharmaceutical attributes, sustained release over 48 hours, and significantly enhanced cytotoxic effects against MCF-7 breast cancer cells compared to native Piperine.", "population_specificity": "In vitro study using MCF-7 breast cancer cell line.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:01.635010+00:00"}
{"study_id": 31956, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the antiangiogenic efficacy of Piperine (PPR) against VEGF-A and VEGFR-2 in Glioblastoma (GBM) and elucidate its mechanism of action.", "results_summary": "Piperine demonstrated dose-dependent inhibition of U87-induced neoangiogenesis, reducing VEGF-A and VEGFR-2 transcript expression at noncytotoxic concentrations (\u226411 \u00b5M), with superior effectiveness compared to nimbolide and trans-chalcone.", "population_specificity": "U87 (Uppsala 87 Malignant Glioma) cell lines and chick chorioallantoic membrane (CAM) models.", "effective_dosage": "\u226411 \u00b5M (non-cytotoxic dose)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:02.547602+00:00"}
{"study_id": 31958, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore piperine's potential role in cancer chemoprevention and its ability to enhance conventional cancer treatments.", "results_summary": "The study found that piperine exhibits antioxidant, anti-inflammatory, and immunomodulatory effects, inhibiting molecular events and signaling pathways linked to cancer development. It also enhances the effectiveness of treatments like UV-phototherapy and TRAIL-based therapy.", "population_specificity": "Not specified (general cancer-related mechanisms discussed).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:04.481729+00:00"}
{"study_id": 31962, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate piperine-induced apoptosis and autophagy in HSC-3 human oral cancer cells and its effects on tumor growth in vivo.", "results_summary": "Piperine reduced HSC-3 cell viability, induced apoptosis and autophagy, and inhibited the PI3K/AKT/mTOR pathway, demonstrating antitumor effects in vivo.", "population_specificity": "HSC-3 human oral cancer cells and in vivo tumor models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:06.266627+00:00"}
{"study_id": 31959, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine if piperine could modulate the non-homologous end-joining (NHEJ) pathway to overcome radioresistance in breast cancer cells.", "results_summary": "Piperine enhanced radiation-induced cell death by altering estrogen receptor \u03b1/\u03b2 ratios, reducing DNA-PK repair complex expression, and increasing DNA damage, leading to cell cycle arrest and apoptosis. It also shared pharmacophore features with known estrogen agonists/antagonists.", "population_specificity": "Estrogen receptor-positive/negative breast cancer cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:06.377226+00:00"}
{"study_id": 31961, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the antitumour efficacy of a liposomal co-delivery system (iRGD-LP-CUR-PIP) containing curcumin and piperine for lung cancer treatment.", "results_summary": "The study found that iRGD-LP-CUR-PIP enhanced tumour targeting, cellular uptake, and antitumour activity in vitro and in vivo, showing significant tumour volume reduction and synergistic effects between curcumin and piperine.", "population_specificity": "Lung cancer models (in vitro and in vivo).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:07.197776+00:00"}
{"study_id": 31960, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the antibacterial and immunomodulatory properties of piperine (PPN) through in vitro, in vivo, and in silico studies.", "results_summary": "The study identified six key aspects of PPN activity, including antibacterial effects, efflux pump inhibition, biofilm disruption, and immune modulation, with most research focusing on Mycobacterium spp. and Staphylococcus aureus. PPN showed potential as an adjuvant in treating bacterial infections, though further exploration of its mechanisms is needed.", "population_specificity": "Primarily Mycobacterium spp. and Staphylococcus aureus in cell lineages and in vivo models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:07.448482+00:00"}
{"study_id": 31953, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective effect of piperine on sepsis-associated encephalopathy (SAE) in C57BL/6 mice subjected to cecum ligation and perforation surgery (CLP).", "results_summary": "Piperine treatment reduced inflammatory markers (IL-6, TBARS), decreased neuronal degeneration, and improved memory in septic mice. It also increased catalase and BDNF levels, demonstrating neuroprotective effects.", "population_specificity": "C57BL/6 male mice subjected to CLP surgery.", "effective_dosage": "20 or 40 mg/kg.", "study_duration": "Short-term (5 days) or long-term (10 days).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:08.830401+00:00"}
{"study_id": 31963, "supplement_id": 1452, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate Piperine's potential biochemical targets, anti-leishmanial mechanisms, and immunomodulatory roles, particularly in combination with meglumine antimoniate.", "results_summary": "Piperine showed binding affinity to IL-12P40 and IFN-\u03b3, enhanced anti-leishmanial effects when combined with meglumine antimoniate, and upregulated Th1-related cytokines while downregulating Th2-related cytokines in treated macrophages.", "population_specificity": "Leishmania major promastigotes, amastigotes, and murine macrophages.", "effective_dosage": "IC50 values of 43.22 \u03bcg/mL (promastigotes) and 19.41 \u03bcg/mL (amastigotes) for the combination therapy.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:11.409387+00:00"}
{"study_id": 31965, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antidepressant-like activity of nanopiperine in LPS-induced depression in mice and compare its effects to pure piperine.", "results_summary": "Nanopiperine reversed LPS-induced depression in mice, improved hippocampal progenitor cell proliferation, increased BDNF levels, and elevated neurotransmitter levels. It also showed better oral bioavailability and stability compared to pure piperine.", "population_specificity": "Mice subjected to LPS-induced stress.", "effective_dosage": "5 and 10 mg/kg body weight for 14 days.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:12.134273+00:00"}
{"study_id": 31964, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the cytotoxic, apoptotic, and anti-cancer effects of piperine (Pip) alone and in combination with sodium pentaborate pentahydrate (NaB) and curcumin (Cur) on hepatocellular carcinoma (HCC) cell lines.", "results_summary": "Piperine alone showed no significant toxic effect on HCC cell lines (HepG2 and Hep3B), but in combination with NaB and Cur, it demonstrated synergistic anti-cancer activity, enhancing cytotoxicity, apoptosis, and cell cycle disruption. Transcriptome analysis confirmed the combined treatment's anti-cancer effects.", "population_specificity": "In vitro study using two HCC cell lines (HepG2 and Hep3B).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:13.821558+00:00"}
{"study_id": 194695, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers sought to determine whether piperine, as a bioenhancer, could improve the bioavailability and bioefficacy of resveratrol when combined with exercise training to increase skeletal muscle mitochondrial capacity.", "results_summary": "The study found that resveratrol plus piperine supplementation significantly increased mitochondrial capacity (40% improvement) compared to placebo (10% improvement) when combined with low-intensity exercise training. No changes were observed in the untrained arm for either group.", "population_specificity": "Healthy young adults (n=16)", "effective_dosage": "10 mg of piperine daily (combined with 500 mg resveratrol)", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:15.684307+00:00"}
{"study_id": 194693, "supplement_id": 1452, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of NSO (250 mg) with 2.5 mg piperine as a supplement for managing allergic rhinitis symptoms.", "results_summary": "The study found that NSO with piperine significantly reduced Total Nasal Symptom Score and Total Ocular Symptoms Score compared to placebo, with no clinically significant adverse effects. Serum Immunoglobulin E levels decreased in the NSO group but were not significantly different from placebo.", "population_specificity": "65 participants aged 18-60 years with allergic rhinitis symptoms.", "effective_dosage": "2.5 mg piperine (BioPerine) twice daily with NSO (250 mg).", "study_duration": "15 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:15.706450+00:00"}
{"study_id": 194696, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of a curcuminoid-piperine combination in improving oxidative stress and inflammation in patients with metabolic syndrome (MetS).", "results_summary": "The curcuminoid-piperine combination significantly improved serum SOD activities and reduced MDA and CRP concentrations compared to placebo, demonstrating strong antioxidant and anti-inflammatory effects. The meta-analysis confirmed a significant reduction in CRP levels with curcuminoid therapy.", "population_specificity": "117 subjects with metabolic syndrome (MetS) according to NCEP-ATPIII criteria.", "effective_dosage": "10 mg/day of piperine co-supplemented with 1 g/day of curcuminoids.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:17.070575+00:00"}
{"study_id": 32166, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Piracetam could mitigate Valproic acid-induced placental toxicity and abnormal fetal development in rats by targeting angiogenesis and oxidative stress.", "results_summary": "Piracetam improved placental histopathology, restored fetal growth metrics, reduced malformations, and enhanced placental angiogenesis while reducing oxidative stress via the VEGF/eNOS/TGF-\u03b2 pathway.", "population_specificity": "Pregnant rats exposed to Valproic acid.", "effective_dosage": "500 mg/kg/day, orally.", "study_duration": "From the 6th to 15th day of gestation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:17.308707+00:00"}
{"study_id": 194699, "supplement_id": 1452, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether co-supplementation of piperine with resveratrol enhances resveratrol's bioavailability and efficacy regarding cognitive function and cerebral blood flow.", "results_summary": "Piperine co-supplementation with resveratrol significantly increased cerebral blood flow during cognitive tasks compared to placebo or resveratrol alone, but did not affect cognitive performance, mood, or blood pressure. Plasma concentrations of resveratrol and its metabolites remained unchanged, suggesting enhanced bioefficacy without altered bioavailability.", "population_specificity": "23 healthy, young adults", "effective_dosage": "20 mg piperine co-administered with 250 mg trans-resveratrol", "study_duration": "Single administration with at least a week between treatments", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:17.787246+00:00"}
{"study_id": 32167, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the neuroprotective potential of a nanoemulsion containing Piracetam and Shatavarin IV for treating Alzheimer's disease, focusing on molecular docking, formulation optimization, and characterization.", "results_summary": "The study found that the nanoemulsion exhibited strong binding affinities with AD-related targets, synergistic effects between Piracetam and Shatavarin IV, enhanced drug release and permeability, and improved antioxidant activity compared to the pure extract.", "population_specificity": "Not specified (in vitro and ex vivo studies, no human participants mentioned).", "effective_dosage": "1:1 ratio of Piracetam and Shatavarin IV (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:20.873221+00:00"}
{"study_id": 32171, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness and safety of CPCGI against piracetam in improving cognitive and functional outcomes in mild to moderate TBI patients.", "results_summary": "The abstract does not provide specific results regarding piracetam's effects, as the study is described as ongoing or not yet concluded.", "population_specificity": "Adult patients with mild to moderate traumatic brain injury (TBI).", "effective_dosage": "20 ml/d (piracetam group)", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:23.136017+00:00"}
{"study_id": 32169, "supplement_id": 1453, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to systematically review the efficacy and safety of piracetam compared to placebo or other medications in children with breath-holding spells (BHS).", "results_summary": "Piracetam significantly increased favorable responses and reduced the frequency of BHS compared to placebo, with comparable adverse effects between groups. Its efficacy was further enhanced by co-administration of docosahexaenoic acid.", "population_specificity": "Children with breath-holding spells (BHS).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Outcomes were assessed at 1, 2, and 3 months post-randomization.", "interactions": "Co-administration with oral docosahexaenoic acid improved efficacy.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:23.339271+00:00"}
{"study_id": 32168, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of piracetam on astrocyte function in rats genetically prone to audiogenic seizures and compare its action in normal rats.", "results_summary": "Piracetam normalized the expression of most astrocyte markers in epileptic rats and enhanced specific markers in normal rats, suggesting its antiepileptic effects may involve astroglia modulation. The study also identified a novel pattern of astrocyte heterogeneity altered in epileptic rats but corrected by piracetam.", "population_specificity": "Krushinsky-Molodkina (KM) rats genetically prone to audiogenic seizures and normal Wistar rats.", "effective_dosage": "100 mg/kg", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:23.557596+00:00"}
{"study_id": 32172, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanism of piracetam for treating spinal cord injury in rats, focusing on the MAPK pathway.", "results_summary": "Piracetam improved motor function recovery, reduced spinal cord lesion area, regulated AQP4 expression to reduce edema, and decreased inflammatory response by modulating the MAPK pathway. The treatment group showed better BBB scores, reduced necrosis, and lower inflammatory markers compared to the injury group.", "population_specificity": "6-week-old female SD rats with induced spinal cord injury.", "effective_dosage": "5 ml\u00b7kg\u207b\u00b9 via tail vein injection, once daily.", "study_duration": "3 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:24.287269+00:00"}
{"study_id": 32173, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore Piracetam's protective effects against cisplatin-induced nephrotoxicity and elucidate its underlying molecular mechanisms.", "results_summary": "Piracetam improved renal function markers, reduced histological damage, exhibited antioxidant and anti-inflammatory effects, and inhibited apoptotic pathways in cisplatin-exposed subjects.", "population_specificity": "Animal model (specific species not mentioned in the abstract)", "effective_dosage": "100 and 300 mg/kg body weight", "study_duration": "15 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:24.440708+00:00"}
{"study_id": 32174, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of piracetam on memory function in adults with cognitive impairment compared to a placebo.", "results_summary": "The meta-analysis of 18 studies found no clinically significant difference in memory enhancement between piracetam and placebo groups (SMD 0.75; 95% CI [-0.19; 1.69]; p=0.12). The study concluded that piracetam's impact on memory remains inconclusive.", "population_specificity": "Adults with impaired cognitive function", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:25.529867+00:00"}
{"study_id": 32175, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to elucidate the effect of Piracetam on oxidative stress and mitochondrial dysfunction in a cellular model of vascular dementia (VaD).", "results_summary": "Piracetam enhanced cell growth, inhibited oxidative stress, and improved mitochondrial function in OGD-stimulated SH-SY5Y cells by inhibiting the PI3K/Akt/mTOR pathway. The findings suggest Piracetam has potential as a treatment for VaD.", "population_specificity": "In vitro cellular model (OGD-stimulated SH-SY5Y cells)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:26.702178+00:00"}
{"study_id": 32176, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to compare the effects of piracetam and iron on heart rate variability (HRV) and treatment effectiveness in children with breath-holding spells.", "results_summary": "Piracetam treatment showed statistically significant improvements in HRV parameters and a significant reduction in the number of breath-holding attacks, indicating positive efficacy.", "population_specificity": "Children aged six months to five years with breath-holding spells (cyanotic or pale types).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:28.420322+00:00"}
{"study_id": 32181, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the protective potential of piracetam against brain injury and inflammation induced by etoposide in a rodent model.", "results_summary": "Piracetam co-treatment counteracted etoposide-induced brain injury and altered serum biomarker levels, suggesting a protective effect against inflammation and brain toxicity.", "population_specificity": "Female albino rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:31.774493+00:00"}
{"study_id": 32178, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Piracetam could mitigate neurological complications, oxidative stress, and mitochondrial dysfunction in a mouse model of hepatic encephalopathy induced by thioacetamide.", "results_summary": "Piracetam significantly improved locomotor activity, reduced oxidative stress biomarkers, decreased inflammatory cytokines, and enhanced mitochondrial function in hyperammonemic mice. The study suggests Piracetam has neuroprotective potential for managing hepatic encephalopathy.", "population_specificity": "Mice with thioacetamide-induced hepatic encephalopathy.", "effective_dosage": "100 and 500 mg/kg, oral.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:31.856616+00:00"}
{"study_id": 32182, "supplement_id": 1453, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the clinical efficacy of intravenous piracetam combined with external ventricular drain and intraventricular urokinase injection in treating intraventricular hemorrhage.", "results_summary": "The experimental group receiving piracetam showed shorter hematoma elimination time, drainage tube removal time, and hospitalization time, along with improved GCS scores, neurological function recovery, and lower surgical complication rates compared to the control group.", "population_specificity": "60 patients with intraventricular hemorrhage at Baoding First Central Hospital, China.", "effective_dosage": "Not specified", "study_duration": "Treatment duration not explicitly stated, but outcomes were measured within one month.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:32.874611+00:00"}
{"study_id": 32180, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if a combination of piracetam and diethylstilbestrol could prevent grand-mal seizures in rats and elucidate the underlying mechanism involving the PI3K/Akt/mTOR pathway.", "results_summary": "The low-dose combination of piracetam (10 mg/kg) and diethylstilbestrol (10 mg/kg) showed synergistic anti-seizure and neuroprotective effects, reducing hippocampal mTOR and proinflammatory cytokines, and improving cell viability in HEK-293 cells exposed to PTZ.", "population_specificity": "Rats (animal study)", "effective_dosage": "Piracetam 10 mg/kg and 20 mg/kg, diethylstilbestrol 10 mg/kg and 20 mg/kg", "study_duration": "14 days", "interactions": "Diethylstilbestrol (co-administered with piracetam)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:33.710177+00:00"}
{"study_id": 32183, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Piracetam could ameliorate Cyclophosphamide-induced hepatotoxicity in rats by modulating apoptotic, necroptotic, and pyroptotic pathways.", "results_summary": "Piracetam significantly improved liver function, reduced markers of apoptosis and inflammation, and corrected histopathological abnormalities caused by Cyclophosphamide. It also shifted the Bax/Bcl-2 ratio toward anti-apoptosis and reduced caspase-3, TNF-\u03b1, and COX-2 expression.", "population_specificity": "Rats (40, divided into four groups)", "effective_dosage": "100 mg/kg and 300 mg/kg body weight", "study_duration": "15 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:34.654428+00:00"}
{"study_id": 32184, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Piracetam, alone and in combination with Citicoline, on hypoxic-ischemic brain damage in rabbit neonates.", "results_summary": "Piracetam reduced neuronal destruction rates (37.5% vs. 45% in the hypoxic-ischemic control group), but its effect was less pronounced than Citicoline alone. The combination of Piracetam and Citicoline showed no superior effect compared to Citicoline alone.", "population_specificity": "Rabbit neonates with induced hypoxic-ischemic brain damage.", "effective_dosage": "100 mg/kg (single dose, frequency not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:36.470972+00:00"}
{"study_id": 32185, "supplement_id": 1453, "safety_score": "80", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of Piracetam and Levetiracetam on reducing the severity and frequency of breath-holding spells (BHS) in children.", "results_summary": "Piracetam significantly reduced the frequency of BHS but had no significant effect on loss of consciousness. It showed a 77.1% partial or complete response rate, which was lower but not significantly different from Levetiracetam's 88.9%.", "population_specificity": "Children aged 6 months to 6 years with severe breath-holding spells.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:36.823681+00:00"}
{"study_id": 32187, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the protective effect of co-administering piracetam and caffeine on scopolamine-induced amnesia in rats.", "results_summary": "Pre-treatment with caffeine and piracetam decreased scopolamine-induced cognitive damage and amnesia, demonstrating improved learning tendency. The mechanism requires further investigation, but the combination shows potential as a novel therapeutic strategy for combating amnesia.", "population_specificity": "Rats with scopolamine-induced amnesia", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:39.624873+00:00"}
{"study_id": 32186, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to evaluate the synergistic effects of piracetam in combination with vinpocetine and cinnarizine for neuroprotective and nootropic benefits.", "results_summary": "The study found that the combination of vinpocetine and piracetam had a higher synergism score (54) compared to piracetam and cinnarizine (25), suggesting better combined efficacy.", "population_specificity": "Model organisms (mice, rats) and neuronal cultures.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:40.067456+00:00"}
{"study_id": 32189, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if systemic piracetam treatment could protect against ischemia-reperfusion injury in musculocutaneous flaps as a simpler alternative to ischemic preconditioning.", "results_summary": "Piracetam significantly reduced myeloperoxidase activity and acute inflammatory cell response, similar to preconditioning, and increased nitric oxide levels, but did not significantly affect vascular proliferation.", "population_specificity": "Rats with latissimus dorsi musculocutaneous flaps.", "effective_dosage": "Systemic piracetam administered 30 minutes before and 6 days after reperfusion (exact dosage not specified).", "study_duration": "6 days post-reperfusion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:42.390753+00:00"}
{"study_id": 32188, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining piracetam with nimodipine improves cognitive function and quality of life in patients with vascular dementia after cerebral infarction.", "results_summary": "The study found that piracetam combined with nimodipine significantly improved cognitive function (measured by ADL, MoCA, ADAS-Cog, and MMSE scores) and quality of life compared to nimodipine alone, with effects becoming more pronounced after 3 months and half a year of treatment.", "population_specificity": "98 patients with vascular dementia after cerebral infarction.", "effective_dosage": "Not specified", "study_duration": "At least half a year (6 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:43.232817+00:00"}
{"study_id": 32190, "supplement_id": 1453, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the muscle-protective effects of piracetam combined with L-carnitine against simvastatin-induced muscle injury and exercise-related myopathic symptoms.", "results_summary": "The study found that the test group (piracetam + L-carnitine) had lower incidence of pain/discomfort and reduced serum levels of muscle injury markers (AST, ALT, LDH) compared to the control group, suggesting a protective effect against simvastatin-induced myalgia. The formulation was also reported as safe and well-tolerated.", "population_specificity": "Healthy male subjects (42 in occasion 1, 19 in occasion 2).", "effective_dosage": "80 mg/mL piracetam + 100 mg/mL L-carnitine, 10 mL oral solution once daily.", "study_duration": "35 consecutive days.", "interactions": "Simvastatin (40 mg once daily).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:45.571477+00:00"}
{"study_id": 32192, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the effect of piracetam, alone and in combination with risperidone, in reversing PTSD-like behavioral and physiological changes in rats.", "results_summary": "Piracetam was effective alone and showed a potentiating effect in combination with risperidone, reversing extinction deficits, behavioral alterations, and restoring neurotransmitter levels, BDNF, inflammatory markers, and oxidative stress markers in the hippocampus and cortex. The combination also normalized plasma corticosterone and nitrite levels.", "population_specificity": "Male Sprague-Dawley rats exposed to a single prolonged stress model (SPS) to induce PTSD-like behaviors.", "effective_dosage": "Not specified", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:46.478333+00:00"}
{"study_id": 32191, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 12, "quality_score": 65, "study_goal": "The researchers aimed to compare the effectiveness of piracetam, theophylline, and iron treatments in reducing the frequency of breath-holding spells (BHS) in children.", "results_summary": "Piracetam showed minimal effectiveness, with only an 8.8% reduction in the frequency of BHS attacks per month, significantly lower than theophylline (82.9%) and iron (58.8%). Parental satisfaction was notably low for piracetam compared to theophylline.", "population_specificity": "146 children (75 girls, 71 boys) with simple breath-holding spells, predominantly cyanotic (83.6%).", "effective_dosage": "40 mg/kg/day in 2 divided doses.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:47.198238+00:00"}
{"study_id": 32193, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the neuroprotective effects of piracetam, alone and in combination with zafirlukast, on L-methionine-induced vascular dementia in rats.", "results_summary": "Piracetam improved neurochemical, behavioral, and histological alterations in rats with L-methionine-induced vascular dementia, with comparable efficacy to zafirlukast and the combination therapy.", "population_specificity": "Male Wistar albino rats", "effective_dosage": "600 mg/kg, orally", "study_duration": "32 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:48.086511+00:00"}
{"study_id": 32194, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to test the efficacy of a novel hybrid nanosystem containing piracetam and vinpocetine in reversing scopolamine-induced memory impairment.", "results_summary": "The nanoformulations (transethosomal, microemulsion, and nanocomposite) effectively reversed scopolamine-induced memory deficits, reduced acetylcholinesterase activity and lipid peroxidation, and demonstrated anti-inflammatory and antiapoptotic effects, with the nanocomposite formulation showing superior performance.", "population_specificity": "Sheep nasal mucosa (preclinical model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:49.897689+00:00"}
{"study_id": 32196, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to explore the associations between piracetam use and NIHSS score changes in ischemic stroke patients, identifying clinical characteristics that influence its effectiveness.", "results_summary": "The study found that piracetam was associated with NIHSS score improvement in specific subgroups, including patients aged \u226575, males, normal/obese weight individuals, ex-smokers, and those with hypertension or dyslipidemia but without diabetes or atrial fibrillation.", "population_specificity": "Ischemic stroke patients from a Taiwanese hospital (excluding those with thrombolytic treatment, incomplete NIHSS scores, or transient ischemic stroke).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:51.984337+00:00"}
{"study_id": 32195, "supplement_id": 1453, "safety_score": "75", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness and safety of oral piracetam versus oral betahistine in managing peripheral vertigo in outpatients.", "results_summary": "Piracetam showed comparable efficacy to betahistine in managing peripheral vertigo, with similar recurrence rates and physician revisit rates. However, piracetam had a higher incidence of adverse events (24% vs. 12%), though the difference was not statistically significant.", "population_specificity": "Outpatients presenting to emergency departments with peripheral vertigo (mean age 54.72 \u00b1 14.09 years, 62% female).", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:52.658910+00:00"}
{"study_id": 32197, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to analyze piracetam's inhibitory effect on AGE formation in glycated albumin and its influence on the interaction between gliclazide and glycated albumin.", "results_summary": "Piracetam strongly inhibited AGE formation in glycated albumin but increased the binding strength of gliclazide to glycated albumin, potentially weakening gliclazide's therapeutic effect. The study suggests caution when combining piracetam and gliclazide in treatment.", "population_specificity": "In vitro study using human serum albumin (HSA) and glycated albumin (gHSAFRC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Interaction with gliclazide noted, potentially weakening its therapeutic effect.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:54.396909+00:00"}
{"study_id": 32198, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to study the relative stability of piracetam polymorphs (P1, P2, P3) under varying temperatures using ssNMR spectroscopy and DFT calculations.", "results_summary": "The study found that DFT calculations could predict the temperature-dependent stability order of piracetam polymorphs and supported polymorphic phase transition analysis in pure and commercial formulations.", "population_specificity": "Not specified (focused on polymorphic forms of piracetam, not human or animal subjects).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:54.465227+00:00"}
{"study_id": 32200, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of the caspase-independent pathway in piracetam-mediated neuroprotection against LPS-induced oxidative stress and inflammation.", "results_summary": "Piracetam treatment significantly protected against LPS-induced oxidative stress, inflammation, and mitochondrial dysfunction, while also inhibiting caspase-independent apoptotic pathways and restoring neuronal integrity.", "population_specificity": "Rat brain (animal model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:55.238145+00:00"}
{"study_id": 32199, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the pharmacological effects of piracetam on binge eating disorder (BED) in female rats, focusing on its impact on binge eating behavior, cognitive deficits, and neurotransmitter levels.", "results_summary": "Piracetam significantly reduced binge eating behavior and associated weight gain, regulated neurotransmitter levels, and alleviated anxiety and cognitive deficits in BED rats. It did not affect normal feeding behavior in the fast-refed model and showed brain region-specific effects on vascular endothelial growth factor expression.", "population_specificity": "Female rats with induced binge eating disorder (BED).", "effective_dosage": "200 mg/kg intraperitoneally (i.p.).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:56.778308+00:00"}
{"study_id": 32201, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether pre-treatment with piracetam could protect cells from apoptosis induced by sonoporation and explore the underlying mechanisms.", "results_summary": "Piracetam pre-treatment protected cells from sonoporation-associated apoptosis by reducing reactive oxygen species, preserving mitochondrial membrane potential, inhibiting caspase-3/7 activity, and enhancing ATP production, thereby improving gene transfection without compromising cell viability.", "population_specificity": "In vitro cell study (specific cell type not mentioned in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:58.388568+00:00"}
{"study_id": 32202, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate Piracetam's role in neuroprotection by examining its effects on mitochondrion-specific factors of the caspase-independent pathway, anti-inflammatory properties, and antioxidative effects.", "results_summary": "Piracetam attenuated LPS-induced cytotoxicity, mitochondrial dysfunction, reactive oxygen species generation, and proinflammatory cytokine expression. It also reduced oxidative DNA fragmentation and PARP-1 up-regulation, demonstrating neuroprotective, anti-inflammatory, and antioxidative properties.", "population_specificity": "Neuronal N2A cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:00.131909+00:00"}
{"study_id": 32203, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Piracetam could protect against ethanol-induced cognitive deficits and neuronal damage by investigating its effects on synaptic plasticity, apoptosis, and autophagy pathways.", "results_summary": "Piracetam improved long-term potentiation, reduced neuronal apoptosis, and modulated autophagy and mTOR/Akt pathways, demonstrating protective effects against ethanol-induced cognitive deficits in juvenile rats.", "population_specificity": "Juvenile rats exposed to ethanol", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:00.403171+00:00"}
{"study_id": 32205, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate piracetam's effects on LPS-induced neuroinflammation and resulting cognitive and behavioral changes.", "results_summary": "Piracetam attenuated LPS-induced anxiety and spatial memory impairment, improved mitochondrial function, reduced oxidative stress, and demonstrated anti-neuroinflammatory effects by lowering IL-6 levels and promoting A\u03b2 efflux from the hippocampus to blood.", "population_specificity": "Animal model (rats) with LPS-induced neuroinflammation.", "effective_dosage": "50, 100, and 200 mg/kg i.p., administered 30 min before LPS infusion and continued for 9 days.", "study_duration": "9 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:03.006370+00:00"}
{"study_id": 32207, "supplement_id": 1453, "safety_score": "90", "efficacy_score": 30, "quality_score": 40, "study_goal": "The researchers aimed to assess the effectiveness of piracetam in reducing the incidence of painful sickle cell disease crises.", "results_summary": "The study found insufficient reliable evidence to support piracetam's routine use for preventing painful sickle cell crises, with mixed and incomplete data on pain reduction and severity. No significant adverse effects were reported, except for one case of dizziness.", "population_specificity": "People of all ages and both sexes with sickle cell disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:07.117826+00:00"}
{"study_id": 32208, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the antioxidant properties and protective effects of piracetam on testicular tissue in a rat model of testicular torsion/detorsion.", "results_summary": "Piracetam (200 mg/kg) significantly reduced oxidative stress (TOS values) compared to the torsion/detorsion group, demonstrating protective effects on testicular tissue. However, its efficacy relative to other treatments (udenafil, dexmedetomidine) was not directly compared in the abstract.", "population_specificity": "Wistar albino rats (n=10 in piracetam group)", "effective_dosage": "200 mg/kg, administered intraperitoneally", "study_duration": "Single dose after 60 minutes of testicular torsion", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:07.525217+00:00"}
{"study_id": 32204, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to review literature on piracetam's use as a heroin adulterant, explore its potential mechanisms, and assess whether it could aid in reducing heroin withdrawal symptoms.", "results_summary": "The study found that piracetam may protect neurons from heroin-induced apoptosis, potentially due to restored beta-endorphin levels and neuroprotective effects. It also suggested piracetam's adulteration in heroin might enhance desirable effects while reducing hangover.", "population_specificity": "Heroin users (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:07.872404+00:00"}
{"study_id": 32206, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether piracetam improves language rehabilitation in post-stroke patients through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "Piracetam showed no significant improvement in overall aphasia severity but demonstrated a pronounced benefit in written language ability. Its effects were short-term, with declining efficacy over time.", "population_specificity": "Post-stroke patients without pre-existing cognitive disorders such as dementia or mood disturbances.", "effective_dosage": "Consistent dose (specific amount not stated), but frequency and therapy duration varied.", "study_duration": "Varied across studies (not specified in abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:07.878094+00:00"}
{"study_id": 32209, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of systemic and topical administration of piracetam on full-thickness skin burn wound healing in rabbits.", "results_summary": "Both systemic (piracetam-IV) and topical (piracetam-C) administration of piracetam significantly enhanced full-thickness burn wound healing, with piracetam-C being more effective and practical. Histopathological analysis showed that wounds treated with piracetam-C resembled those of the control group more closely than other treatments.", "population_specificity": "New Zealand male rabbits with induced full-thickness skin burns.", "effective_dosage": "Not specified in the abstract.", "study_duration": "14 days of administration, with outcomes assessed at 21 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:09.319974+00:00"}
{"study_id": 32210, "supplement_id": 1453, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to compare the efficacy of betahistine plus piracetam dual therapy versus betahistine monotherapy in patients with peripheral vestibular vertigo.", "results_summary": "The study found that betahistine plus piracetam showed statistically significant improvements in DHI functional scores and a higher percentage of patients with no impairment compared to betahistine alone. Adverse events were low and similar in both groups, with no discontinuations due to drug-related effects.", "population_specificity": "Patients with peripheral vestibular vertigo (n=2272, with 114 receiving dual therapy and 567 receiving monotherapy in the analyzed subset).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:09.596226+00:00"}
{"study_id": 32211, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether piracetam enhances heroin's reward properties and its effects on neuronal apoptosis and \u03b2-endorphin levels in the brain.", "results_summary": "Piracetam significantly enhanced heroin-induced conditioned place preference (CPP) but did not induce CPP on its own. It also reduced neuronal apoptosis and normalized \u03b2-endorphin levels in specific brain regions compared to heroin alone.", "population_specificity": "Heroin-treated rats (animal study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:11.466810+00:00"}
{"study_id": 32212, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the neuroprotective effects of piracetam against rotenone-induced oxidative stress in rat brain models.", "results_summary": "Pretreatment with piracetam significantly attenuated rotenone-induced oxidative stress in a region-specific manner, enhancing antioxidant capacity in brain cells. Co-treatment with piracetam did not show significant protection in ex vivo studies.", "population_specificity": "Rats (animal model)", "effective_dosage": "600 mg/kg body weight (oral, daily)", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:15.231628+00:00"}
{"study_id": 32216, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether mitochondrion-specific endonuclease G is involved in piracetam's protective mechanisms against LPS-induced damage in astrocytes.", "results_summary": "Piracetam attenuated LPS-induced decreases in cell viability, mitochondrial activity, oxidative stress, chromatin condensation, and DNA fragmentation. It also inhibited LPS-induced translocation of endonuclease G to the nucleus, suggesting a protective role.", "population_specificity": "Astrocyte glial cells (in vitro)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:16.140534+00:00"}
{"study_id": 32215, "supplement_id": 1453, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the therapeutic efficacy of piracetam and dimenhydrinate in reducing vertigo symptoms in emergency department patients.", "results_summary": "The study found no significant difference between piracetam and dimenhydrinate in reducing vertigo intensity, with similar rescue medication needs and only one reported adverse reaction.", "population_specificity": "Healthy adult patients presenting to the emergency department with undifferentiated vertigo.", "effective_dosage": "2000 mg intravenous piracetam (single dose).", "study_duration": "30 minutes post-administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:16.345269+00:00"}
{"study_id": 32213, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to assess the nootropic activity of piracetam alone and in combination with duloxetine in mice.", "results_summary": "Piracetam alone showed significant improvements in memory tasks (reduced transfer latency in EPM and increased time in target quadrant in MWM), but the combination with duloxetine did not produce statistically significant nootropic effects and failed to increase brain monoamine levels except for norepinephrine in the hippocampus.", "population_specificity": "Male Swiss Albino mice", "effective_dosage": "100 mg/kg (piracetam alone), 50 mg/kg (piracetam in combination)", "study_duration": "Not specified", "interactions": "Combination with duloxetine showed no cognitive benefits and limited monoamine level increases.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:16.599743+00:00"}
{"study_id": 32217, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effect of piracetam on peripheral neuropathic pain in rats.", "results_summary": "Piracetam at 200 mg/kg significantly reduced neuropathic pain symptoms (thermal hyperalgesia and cold allodynia), while lower doses (50 and 100 mg/kg) showed limited or no effect.", "population_specificity": "Rats with chronic constriction injury-induced neuropathic pain.", "effective_dosage": "50, 100, and 200 mg/kg administered intraperitoneally.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:17.515549+00:00"}
{"study_id": 32218, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanism by which piracetam reduces neuronal damage induced by oxygen and glucose deprivation (OGD) in rat primary cortical cells.", "results_summary": "Piracetam significantly reduced neuronal damage, oxidative stress, and excitatory amino acid release while enhancing antioxidant enzyme activity and lowering P53/Bax protein expression in OGD-exposed cortical cells.", "population_specificity": "Rat primary cortical cells subjected to oxygen and glucose deprivation (OGD).", "effective_dosage": "Added to cultured cells 12 hours before OGD (specific dosage not mentioned).", "study_duration": "4 hours of OGD exposure after 12-hour pre-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:18.766141+00:00"}
{"study_id": 32219, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effect of piracetam on cognitive performance in patients undergoing coronary bypass surgery.", "results_summary": "The meta-analysis found that piracetam significantly improved short-term cognitive performance in patients, as evidenced by better scores in multiple SKT subtests compared to placebo. The results were statistically significant across several cognitive domains.", "population_specificity": "Patients undergoing coronary bypass surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:19.431415+00:00"}
{"study_id": 32220, "supplement_id": 1453, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effectiveness and side effects of intravenous piracetam versus dimenhydrinate in treating acute peripheral vertigo in emergency department patients.", "results_summary": "Piracetam was found to be as effective as dimenhydrinate in treating acute vertigo but had about half the side effects, with drowsiness being the most common. The study concluded that piracetam could be more frequently used due to its better safety profile and effectiveness for both acute and chronic vertigo.", "population_specificity": "200 patients aged 18-70 diagnosed with peripheral vertigo in an emergency department setting.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:24.552006+00:00"}
{"study_id": 32221, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of piracetam on cognitive, motor, and endogenous defense functions in a rat model of cerebral global ischemic/reperfusion injury.", "results_summary": "Piracetam improved neurological and histopathological alterations, reduced water content and infarct size, but did not significantly restore or prevent impaired endogenous defense functions compared to the control group.", "population_specificity": "Rats subjected to bilateral common carotid artery occlusion (BCCAO) for 30 minutes followed by 24-hour reperfusion.", "effective_dosage": "Not specified", "study_duration": "Intervention duration not specified (assessment occurred after 24-hour reperfusion).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:24.887956+00:00"}
{"study_id": 32222, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the metabolic pathways of piracetam in human liver microsomes and identify cytochrome P450 isoforms responsible for its metabolism.", "results_summary": "The study identified 2-(2-oxopyrrolidin-1-yl) acetic acid (M1) as the sole metabolite of piracetam in human liver microsomes and developed a validated method for detecting M1 in rat plasma for pharmacokinetic studies. Computer modeling suggested additional potential metabolites, but only M1 was detected experimentally.", "population_specificity": "Human liver microsomes and rat plasma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:25.199476+00:00"}
{"study_id": 32223, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether piracetam has anti-nociceptive (pain-relieving) effects and to explore its mechanisms of action in inflammatory pain models.", "results_summary": "Piracetam reduced pain-like behavior in multiple inflammatory pain models, diminished hyperalgesia, and inhibited cytokine production and oxidative stress, demonstrating analgesic activity dependent on these mechanisms.", "population_specificity": "Not specified (animal models inferred from methods).", "effective_dosage": "Not specified (dose-dependent effects noted but exact amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:25.418492+00:00"}
{"study_id": 32224, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of piracetam in rotenone-induced Parkinsonism in rats, focusing on motor performance, biochemical markers, and histopathological changes.", "results_summary": "Piracetam significantly reversed locomotor deficits, increased striatal dopamine levels, and reduced TNF-\u03b1 production in rotenone-treated rats, demonstrating neuroprotective effects.", "population_specificity": "Male rats with rotenone-induced Parkinsonism.", "effective_dosage": "100 and 200 mg/kg/day, orally.", "study_duration": "Not explicitly stated, but rotenone was administered over 6 doses (48-hour intervals).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:26.172539+00:00"}
{"study_id": 32226, "supplement_id": 1453, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of piracetam (40mg/kg/day) in preventing and controlling breath-holding spells (BHS) in children.", "results_summary": "Piracetam showed an 81% response rate after one month and 91% control of BHS by the end of the study, significantly outperforming placebo (16%). No significant difference in side effects was observed between the groups.", "population_specificity": "150 children (86 boys) aged 6-24 months with severe breath-holding spells.", "effective_dosage": "40mg/kg/day, administered twice daily.", "study_duration": "3 months (with monthly follow-ups).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:28.631468+00:00"}
{"study_id": 32225, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether piracetam mimics the neuroprotective and antihypoxic effects of the endogenous cyclic dipeptide cycloprolylglycine (CPG).", "results_summary": "CPG showed antihypoxic activity at 0.5 and 1.0 mg/kg in outbred and BALB/c mice but not in C57B1/6 mice. Neuroprotective effects were observed at concentrations of 10^(-5) to 10^(-8) M when administered 24 hours before toxin exposure, supporting the hypothesis that piracetam is a CPG mimetic.", "population_specificity": "Outbred mice, BALB/c mice, C57B1/6 mice, and human neuroblastoma SH-SY5Y cells.", "effective_dosage": "0.5 and 1.0 mg/kg (i.p.) for antihypoxic activity; 10^(-5) to 10^(-8) M for neuroprotective effects.", "study_duration": "Treatment was administered 24 hours before toxin introduction for neuroprotective effects.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:31.092878+00:00"}
{"study_id": 32229, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to compare the histological effects of piracetam, dexamethasone, and memantine on cellular apoptosis caused by cisplatin ototoxicity in rats.", "results_summary": "Piracetam reduced the apoptosis rate, but the effect was not statistically significant. Dexamethasone and memantine showed significant effects, making them superior to piracetam in reducing cisplatin-induced ototoxicity.", "population_specificity": "36 rats", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:32.377533+00:00"}
{"study_id": 32227, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to compare the effects of piracetam and liothyronine on memory subscales (orientation, personal information, mental control) in patients undergoing ECT.", "results_summary": "Piracetam showed no significant difference compared to placebo or liothyronine in personal information, orientation, or mental control. Memory changes due to ECT were limited to orientation, but piracetam did not demonstrate superior efficacy.", "population_specificity": "Patients aged 20-45 undergoing ECT (n=60).", "effective_dosage": "Not specified", "study_duration": "From first ECT session until 1 month after the last session.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:32.659888+00:00"}
{"study_id": 32231, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to assess the effects of piracetam on method of delivery and perinatal morbidity in cases of suspected fetal distress during labor.", "results_summary": "Piracetam showed a trend toward reducing the need for cesarean section but did not demonstrate statistically significant differences in neonatal morbidity or Apgar scores compared to placebo. The authors concluded there was insufficient evidence to evaluate its use for fetal distress.", "population_specificity": "96 women with suspected fetal distress during labor.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:32.859188+00:00"}
{"study_id": 32228, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of piracetam on reducing death and disability in people with acute, presumed ischemic stroke.", "results_summary": "Piracetam was associated with a non-significant increase in death at one month, though this trend disappeared after correcting for baseline stroke severity differences. Limited data showed no difference in functional outcome, dependence, or proportion of patients dead or dependent between treatment and control groups.", "population_specificity": "Adults aged 40-85 with acute, presumed ischemic stroke, with both sexes equally represented.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:32.862107+00:00"}
{"study_id": 32230, "supplement_id": 1453, "safety_score": "40", "efficacy_score": 60, "quality_score": 30, "study_goal": "The researchers aimed to examine the effects of Piracetam on cognitive impairment in patients with contrasting psychiatric backgrounds.", "results_summary": "One patient with organic amnestic syndrome showed significant improvement, while another with organic personality change and a family history of mental illness experienced worsening behavioral problems after Piracetam use. The study highlights caution in prescribing Piracetam to those with psychiatric histories.", "population_specificity": "Patients with cognitive impairment, including one with organic amnestic syndrome and another with organic personality change and a family history of mental illness.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:33.735148+00:00"}
{"study_id": 32233, "supplement_id": 1453, "safety_score": "100", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of piracetam in treating breath-holding spells (BHS) in children.", "results_summary": "Piracetam significantly reduced the number of BHS attacks compared to placebo (p < 0.001), with no reported side effects during the study. The median number of attacks/month declined from 5.5 to 1 in the piracetam group, while the placebo group showed no significant change.", "population_specificity": "Forty children with breath-holding spells, divided into two groups (piracetam and placebo).", "effective_dosage": "Not specified in the abstract.", "study_duration": "4 months (with monthly follow-ups).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:38.194112+00:00"}
{"study_id": 32234, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective effects of piracetam against LPS-induced oxidative stress and DNA damage in leukocytes and macrophages.", "results_summary": "Piracetam pretreatment significantly protected against LPS-induced increases in ROS levels and DNA damage in both in vivo and ex vivo experiments, demonstrating its salutary effect on oxidative stress.", "population_specificity": "Sprague Dawley rats, isolated rat blood leukocytes, and rat macrophage cell line J774A.1.", "effective_dosage": "600mg/kg, oral, for five consecutive days.", "study_duration": "Five days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:40.087132+00:00"}
{"study_id": 32236, "supplement_id": 1453, "safety_score": "80", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether 6 months of piracetam treatment improves post-stroke aphasia compared to placebo.", "results_summary": "Piracetam showed no significant benefit over placebo for most clinical parameters and aphasia scores, except for a slight improvement in auditory comprehension. The study concluded that piracetam has no clear beneficial effect on post-stroke language disorders.", "population_specificity": "Thirty patients with first-ever ischemic strokes and severe aphasia.", "effective_dosage": "4.8 g daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:40.889812+00:00"}
{"study_id": 32235, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of piracetam on flap survival, ischemia-reperfusion injury, and VEGF expression in a rat model.", "results_summary": "Piracetam significantly reduced necrosis area in both ischemic and nonischemic flaps and increased VEGF expression in ischemia-reperfusion-induced flaps, though blood flow rates did not differ significantly between treated and untreated groups.", "population_specificity": "36 rats in an unipedicled epigastric flap model.", "effective_dosage": "Not specified (administered 30 minutes before reperfusion and postoperatively for 7 days).", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:41.023871+00:00"}
{"study_id": 32237, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether piracetam could improve mitochondrial function and mitigate the detrimental effects of beta-amyloid peptide (Abeta) in brain cells, particularly in the context of Alzheimer's disease.", "results_summary": "Piracetam improved mitochondrial function in PC12 cells and dissociated brain cells exposed to Abeta(1-42), reduced soluble Abeta load in transgenic mice, and enhanced neurite outgrowth in PC12 cells. It also counteracted oxidative stress-induced Abeta production in HEK cells.", "population_specificity": "PC12 and HEK cell lines, dissociated brain cells from young and aged NMRI mice, and mice transgenic for mutant human amyloid precursor protein (APP).", "effective_dosage": "Not specified", "study_duration": "14 days for transgenic mice", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:42.371316+00:00"}
{"study_id": 32239, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the structural binding mechanisms of piracetam on AMPA receptor subtypes GluA2 and GluA3 to understand its potential as an allosteric modulator.", "results_summary": "Piracetam binds to multiple sites along the dimer interface of AMPA receptors with low occupation, including a unique binding site that may be important for designing new allosteric regulators. The binding differs significantly from aniracetam, which binds symmetrically at the dimer interface center.", "population_specificity": "Not specified (in vitro study on receptor subtypes)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:42.457820+00:00"}
{"study_id": 32238, "supplement_id": 1453, "safety_score": "75", "efficacy_score": 68, "quality_score": 82, "study_goal": "The researchers aimed to evaluate the clinical outcomes, pharmacology, and safety of piracetam and its derivatives for various CNS disorders, focusing on evidence from the past 10 years.", "results_summary": "Piracetam showed neuroprotective effects during coronary bypass surgery and effectiveness for cognitive disorders of cerebrovascular/traumatic origin, but limited long-term benefits for mild cognitive impairment. It had a stronger effect on lowering depression and anxiety than improving memory and showed benefits as add-on therapy for myoclonus epilepsy and tardive dyskinesia.", "population_specificity": "Patients with CNS disorders (cognition/memory, epilepsy, neurodegenerative diseases, stroke/ischemia, stress, and anxiety).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Additive beneficial effect noted when combined with a vasodilator drug.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:42.505304+00:00"}
{"study_id": 32232, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the neuroprotective potential of piracetam, silymarin, and protocatechuic acid ethyl ester (PCA) in focal ischemic rats.", "results_summary": "Piracetam improved behavioral and histopathological changes, reduced water content, and decreased infarct size, but did not significantly affect biochemical markers like silymarin and PCA.", "population_specificity": "Focal ischemic rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:43.181257+00:00"}
{"study_id": 32240, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether piracetam could reverse cognitive dysfunction and oxidative stress induced by propoxur in the brain.", "results_summary": "Piracetam (400mg/kg/d) effectively reversed propoxur-induced cognitive deficits and oxidative stress, as evidenced by improved step-down latency, reduced transfer latency, and normalized brain MDA and NP-SH levels.", "population_specificity": "Animal model (specific species not mentioned in the abstract).", "effective_dosage": "400mg/kg/d, intraperitoneal administration.", "study_duration": "1 week.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:46.662602+00:00"}
{"study_id": 32241, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine whether piracetam, alone or in combination with acyclovir, provided additional benefits in treating idiopathic sudden hearing loss compared to standard combined treatment.", "results_summary": "The study found no significant difference in hearing improvement between groups receiving piracetam, acyclovir, or their combination compared to standard treatment alone, concluding no additional benefit from these drugs.", "population_specificity": "81 patients (44 males, 37 females; mean age 40.4 years) with idiopathic sudden hearing loss.", "effective_dosage": "Not specified", "study_duration": "10 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:48.841291+00:00"}
{"study_id": 32243, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the impact of general anesthesia on children's memory and evaluate the effectiveness of piracetam in preventing postoperative cognitive dysfunction.", "results_summary": "The study found that general anesthesia impaired memory, particularly long-term memory, in children. Intravenous piracetam administration improved cognitive function postoperatively.", "population_specificity": "Children undergoing various surgical procedures under general anesthesia.", "effective_dosage": "30 mg/kg intravenously (single dose postoperatively).", "study_duration": "Intervention was administered once postoperatively; cognitive function was assessed over 10 consecutive days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:49.595221+00:00"}
{"study_id": 32249, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to determine the effectiveness of piracetam as a prophylactic treatment for severe breath-holding spells (BHS) in children.", "results_summary": "Piracetam was effective in completely eliminating spells in 81% of children and reducing frequency/intensity in 9%. Prophylaxis was administered for a mean duration of 5 months.", "population_specificity": "Children aged 4 weeks to 5 years (mean 17 months) diagnosed with severe BHS.", "effective_dosage": "50-100 mg/kg/day", "study_duration": "3-6 months (mean 5 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:51.658357+00:00"}
{"study_id": 32242, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to determine the effectiveness of piracetam, alone and in combination with antiepileptic drugs, in treating action myoclonus in a patient with Lance-Adams syndrome.", "results_summary": "A lower dose of piracetam (15 g/day) combined with valproate sodium and clonazepam was ineffective, but increasing the dose to 21 g/day significantly improved freezing gait and walking ability, along with reduced cortical hyperexcitability. The study concluded that piracetam's efficacy in treating action myoclonus is dose-dependent.", "population_specificity": "A 17-year-old female with Lance-Adams syndrome caused by anoxic encephalopathy.", "effective_dosage": "15 g/day (ineffective) and 21 g/day (effective).", "study_duration": "Not specified.", "interactions": "Combined with valproate sodium and clonazepam.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:51.980298+00:00"}
{"study_id": 32248, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to compare the therapeutic effects of atomoxetine and piracetam in children with ADHD.", "results_summary": "Piracetam showed high effectiveness in treating ADHD, though its therapeutic effect was less pronounced and took longer to manifest compared to atomoxetine. Both treatments were more effective than no pharmacological therapy.", "population_specificity": "Children aged 6 to 13 years with ADHD.", "effective_dosage": "50-70 mg/kg daily.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:52.123986+00:00"}
{"study_id": 32247, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effect of piracetam on brain tissue and serum nitric oxide levels in dogs subjected to hemorrhagic shock.", "results_summary": "Piracetam improved blood pressure and pulse rates more than saline treatment alone and showed greater recovery in brain damage compared to the control group, though no correlation with nitric oxide levels was found.", "population_specificity": "Dogs subjected to hemorrhagic shock.", "effective_dosage": "Not specified", "study_duration": "180 minutes (measurements taken at 60, 120, and 180 minutes post-intervention)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:52.125306+00:00"}
{"study_id": 32244, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy of piracetam in treating cognitive and motor impairments in adolescents with a history of moderate to severe closed craniocerebral trauma.", "results_summary": "Piracetam demonstrated positive therapeutic effects on higher mental functions (memory, attention, executive) and motor coordination, as well as improvements in the speed of cognitive and motor operations compared to the control group.", "population_specificity": "Adolescents aged 12-18 years with a history of moderate to severe closed craniocerebral trauma occurring 1.5-5 years prior to the study.", "effective_dosage": "40-50 mg/kg daily (total daily dose 1600-2400 mg).", "study_duration": "One month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:52.348257+00:00"}
{"study_id": 32251, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to determine the genotype-dependent effects of neonatal piracetam administration on audiogenic seizure susceptibility in mice.", "results_summary": "Piracetam reduced seizure intensity in DBA/2J mice but increased it in CBA and 101/HY strains, indicating genotype-dependent effects. The study found no uniform efficacy across different mouse strains.", "population_specificity": "Neonatal DBA/2J, 101/HY, and CBA/Lac/Sto mice (2-7 days old).", "effective_dosage": "50 mg/kg, single subcutaneous injection.", "study_duration": "Single administration, effects assessed at 1 month of age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:56.675987+00:00"}
{"study_id": 32252, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the early effect of piracetam combined with steroids in treating acute acoustic trauma (AAT) in soldiers exposed to intense gunfire noise.", "results_summary": "The study found that 69% of patients showed hearing improvement (complete or partial recovery) after one month of treatment, with the highest recovery rate (65%) in the group treated within the first hour. The immediate onset of treatment (group A) resulted in statistically better hearing thresholds compared to delayed treatment groups.", "population_specificity": "Young soldiers exposed to intense gunfire noise (G3 rifle).", "effective_dosage": "Not specified", "study_duration": "One month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:57.306437+00:00"}
{"study_id": 32253, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the efficacy of piracetam in treating cognitive and motor function impairments in adolescents with moderate to severe closed traumatic brain injury.", "results_summary": "The study demonstrated positive therapeutic effects of piracetam on cognitive functions (memory, attention, executive functions) and motor functions (coordination), as well as improvements in the speed of cognitive and motor performance.", "population_specificity": "Adolescents aged 12-18 years with a history of moderate to severe closed traumatic brain injury occurring 1.5-5 years prior.", "effective_dosage": "40-50 mg/kg (or 1600-2400 mg daily)", "study_duration": "One month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:59.159604+00:00"}
{"study_id": 32256, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to investigate the efficacy of high-dose piracetam in improving gait ataxia in patients with autosomal dominant cerebellar ataxia.", "results_summary": "The study found a statistically significant improvement in patients' total score on the International Cooperative Ataxia Rating Scale, particularly in posture and gait disturbances. The results suggest high-dose piracetam may reduce disability by improving gait ataxia.", "population_specificity": "Eight patients with autosomal dominant cerebellar ataxia.", "effective_dosage": "60 g/day intravenously.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:00.489405+00:00"}
{"study_id": 32258, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Piracetam on memory impairment, neuronal damage, and synaptic plasticity in rats with chronic cerebral hypoperfusion.", "results_summary": "Piracetam improved memory impairment, increased hippocampal amino acid content, and reduced neuronal damage in rats with induced cerebral hypoperfusion. It also attenuated deficits in long-term potentiation and reduced overexpression of apoptosis-related proteins (BAX and P53).", "population_specificity": "Chronic cerebral hypoperfused rats (bilateral common carotid artery occlusion model).", "effective_dosage": "600 mg/kg, once per day.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:01.121501+00:00"}
{"study_id": 32255, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of piracetam on NMDA and nACh receptor binding sites in mice with high (EH) and low (EL) exploratory efficacy.", "results_summary": "Piracetam increased NMDA receptor binding sites by 70% in EL mice but decreased nACh receptor density in both EL (55%) and EH (40%) mice. Meclofenoxate also reduced nACh receptor density but increased NMDA receptor binding sites in EH mice.", "population_specificity": "Outbred ICR strain mice divided into high (EH) and low (EL) exploratory efficacy groups.", "effective_dosage": "200 mg/kg, once per day", "study_duration": "5 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:01.182644+00:00"}
{"study_id": 32254, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the efficacy of high-dose piracetam in treating children with Kozhevnikov epilepsy syndrome (epilepsia partialis continua).", "results_summary": "Piracetam reduced myoclonus frequency by 75% in half the patients and stopped it completely in the other half, decreased focal clonic seizures, and improved neurological and cognitive functioning in most patients. Clinical improvement lasted 1-2 months post-treatment.", "population_specificity": "6 children aged 9-16 years with Kozhevnikov epilepsy.", "effective_dosage": "Mean dose of 1g/kg/day (up to 35 g/day) intravenously.", "study_duration": "30 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:01.690996+00:00"}
{"study_id": 32257, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy of piracetam as a positive modulator of AMPA-sensitive glutamate receptors in improving symptoms of autistic disorder when combined with risperidone.", "results_summary": "The study found that piracetam combined with risperidone significantly improved Aberrant Behavior Checklist-Community (ABC-C) Rating Scale scores compared to placebo plus risperidone, with a statistically significant difference between the two groups. The results suggest synergistic effects of combining piracetam with atypical antipsychotics in treating autism.", "population_specificity": "40 children aged 3-11 years with a DSM IV clinical diagnosis of autism and severely disruptive symptoms.", "effective_dosage": "Piracetam was titrated up to 800 mg/day.", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:02.892518+00:00"}
{"study_id": 32260, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the role of opiatergic mechanisms in the antiamnestic effects of piracetam and its interaction with morphine-induced effects in mice.", "results_summary": "Piracetam reversed drug- or electrically-induced amnesia but decreased the antinociceptive effect of morphine, suggesting opiatergic system involvement in its antiamnestic action.", "population_specificity": "Mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Interaction with morphine noted (decreased antinociceptive effect)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:05.773349+00:00"}
{"study_id": 32259, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to reexamine the efficacy of oral piracetam in reducing symptoms of tardive dyskinesia in patients with schizophrenia or schizo-affective disorders.", "results_summary": "Piracetam significantly improved symptoms of tardive dyskinesia, with notable reductions in clinical global impression, tardive parkinsonism, and tardive dyskinesia subscale scores compared to placebo. The placebo group showed minimal improvement or slight deterioration.", "population_specificity": "40 DSM-IV schizophrenic and schizo-affective patients with DSM-IV-TR tardive dyskinesia.", "effective_dosage": "4800 mg/day", "study_duration": "4 weeks per treatment phase (total 9 weeks including washout)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:06.300716+00:00"}
{"study_id": 32261, "supplement_id": 1453, "safety_score": "90", "efficacy_score": 30, "quality_score": 40, "study_goal": "To assess the effectiveness of piracetam for reducing the incidence of painful sickle cell disease crises.", "results_summary": "The study found insufficient reliable evidence to support piracetam's routine use for preventing painful sickle cell crises, with mixed and incomplete data on pain reduction and no significant difference in hospitalization days. Participant satisfaction was reported but not detailed, and adverse effects were minimal (only one case of dizziness).", "population_specificity": "People of all ages and both sexes with sickle cell disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:08.116462+00:00"}
{"study_id": 32264, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Piracetam on learning, memory, brain metabolism, membrane fluidity, and its potential therapeutic benefits in disorders like dementia, vertigo, myoclonus, and stroke.", "results_summary": "Piracetam improved learning, memory, and brain metabolism, enhanced membrane fluidity, protected against hypoxia, increased red cell deformability, normalized platelet aggregation, and demonstrated antithrombotic, neuroprotective, and rheological properties.", "population_specificity": "Not specified (general discussion of mechanisms and potential applications).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:09.759123+00:00"}
{"study_id": 32263, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess the effects of piracetam on reducing death and disability in people with acute presumed ischaemic stroke.", "results_summary": "Piracetam was associated with a non-significant increase in death at one month, though this trend disappeared after correcting for stroke severity imbalance. Limited data showed no difference in functional outcomes, dependency, or proportion of patients dead or dependent between treatment and control groups.", "population_specificity": "Adults aged 40-85 with acute presumed ischaemic stroke, both sexes equally represented.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:09.944194+00:00"}
{"study_id": 32265, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether piracetam improves mitochondrial dysfunction caused by oxidative stress and aging.", "results_summary": "Piracetam improved mitochondrial membrane potential and ATP production in PC12 cells and dissociated brain cells, particularly in aged animals, and reduced caspase 9 activity. It also lowered elevated antioxidant enzyme activities in aged mouse brains.", "population_specificity": "PC12 cells, dissociated brain cells from mice (young and aged).", "effective_dosage": "100-1000 \u00b5M (in vitro), 100-500 mg/kg daily (in vivo).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:10.299516+00:00"}
{"study_id": 194700, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Piracetam as a treatment for tardive dyskinesia (TD) in patients receiving antipsychotic therapy.", "results_summary": "The abstract suggests possible improvements in TD symptoms with Piracetam, though the evidence is not detailed or conclusive. The study reviews multiple pharmacological agents, including Piracetam, but does not provide specific outcome data for it.", "population_specificity": "Patients with tardive dyskinesia receiving antipsychotic treatment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:11.587192+00:00"}
{"study_id": 32262, "supplement_id": 1453, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of piracetam in treating postoperative cognitive impairment after coronary artery bypass grafting (CABG).", "results_summary": "Piracetam showed a statistically significant improvement in cognitive function six weeks after CABG in the per-protocol population and a trend toward significance in the intent-to-treat population. Anxiety decreased in both groups, but no significant cognitive improvement was observed in the placebo group.", "population_specificity": "Patients undergoing coronary artery bypass grafting (CABG) (n = 98).", "effective_dosage": "Intravenous (150 mg/kg daily; 300 mg/kg on the day of surgery) followed by oral (12 g/day).", "study_duration": "From the day before surgery to 6 weeks after surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:12.142333+00:00"}
{"study_id": 32667, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a one-year personalized plant-based dietary intervention could reduce DNA damage in post-surgery, non-metastatic colorectal cancer patients.", "results_summary": "The study found a significant 32% reduction in DNA base oxidation in the intervention group compared to the control group, but no significant effect on DNA strand breaks. Adherence to a plant-based dietary pattern may reduce DNA base oxidation in these patients.", "population_specificity": "Post-surgery, non-metastatic colorectal cancer patients aged 50-80 years (stage I-III).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:15.018975+00:00"}
{"study_id": 32666, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine metabolomic profiles in response to the portfolio diet (a cholesterol-lowering plant-based diet) compared to a control vegetarian diet and a control diet with a statin.", "results_summary": "The study found significant changes in metabolites (e.g., glycerophosphocholines, triacylglycerols) associated with the portfolio diet, reflecting its plant-based nature and cholesterol-lowering effects. Fifty-two metabolites consistently changed in the same direction across both RCTs.", "population_specificity": "Adults with high LDL-C (>4.1 mmol/L), aged 58.4 \u00b1 8.6 years (first RCT) and 61.0 \u00b1 9.6 years (second RCT).", "effective_dosage": "Not specified (all foods were provided).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:16.003809+00:00"}
{"study_id": 32669, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine whether feed efficiency-related traits in Pacific whiteleg shrimp exhibit diet-specific genetic variations and genotype-by-diet interactions when comparing a plant-based (fishmeal-free) diet to a fishmeal-based diet.", "results_summary": "The plant-based diet resulted in significantly higher residual feed intake (RFI) and lower average daily weight gain (ADG) compared to the fishmeal-based diet, indicating reduced yields and potential profitability impacts. Genetic correlations suggested genotype \u00d7 diet interactions, particularly for ADG, highlighting the need for selective breeding to improve feed efficiency in plant-based diets.", "population_specificity": "Pacific whiteleg shrimp (Penaeus vannamei)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:18.850589+00:00"}
{"study_id": 32670, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess whether plant-based diets associate with frailty risk in older adults and whether this association is moderated by sex and income.", "results_summary": "A healthful plant-based diet (hPDI) was associated with lower odds of frailty, while an unhealthful plant-based diet (uPDI) was linked to higher frailty risk, particularly among men with low income. The association for uPDI was moderated by income and sex, but not for hPDI.", "population_specificity": "Older adults (mean age 55.48 \u00b1 7.87) from the UK Biobank cohort (n = 73,180).", "effective_dosage": "Not specified", "study_duration": "Cross-sectional (baseline data only)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:19.054212+00:00"}
{"study_id": 32668, "supplement_id": 1454, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to investigate how increasing plant food diversity impacts metabolomic, microbiome, and clinical parameters in individuals with moderate chronic kidney disease (CKD).", "results_summary": "The high-diversity plant-based diet (HDPD) improved diet quality, reduced renal acid load, decreased symptom burden, and shifted the gut microbiome toward beneficial metabolites, while the low-diversity diet reduced microbial diversity. Uremic toxin reductions were significant in responders with poorer kidney function.", "population_specificity": "25 Australian adults with stage 3-4 CKD.", "effective_dosage": "\u226530 unique plant foods weekly (HDPD) vs. \u226415 unique plant foods weekly (LDPD).", "study_duration": "6 weeks per diet, with a 4-week washout period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:19.261617+00:00"}
{"study_id": 32671, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of a whole foods, plant-based (WFPB) diet, combined with physical activity and stress management, on cardiovascular risk factors in military veterans with atherosclerotic heart disease and/or type 2 diabetes.", "results_summary": "The intervention led to statistically significant improvements in waist circumference, systolic blood pressure, LDL cholesterol, fasting glucose, and hemoglobin A1c. Participants with type 2 diabetes showed additional improvements in hemoglobin A1c and diastolic blood pressure.", "population_specificity": "Military veterans (mean age 69.2 years, 97% male) with atherosclerotic heart disease and/or type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "15 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:20.353790+00:00"}
{"study_id": 32672, "supplement_id": 1454, "safety_score": "85", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine whether a defined, plant-based diet, alone or combined with alternative therapies, could improve outcomes in Stage C and D HFrEF patients who failed guideline-directed medical therapy.", "results_summary": "The study found that a plant-based diet, sometimes combined with alternative therapies, improved LVEF and RVSP, reduced medication needs and body weight, and enhanced quality of life in HFrEF patients.", "population_specificity": "Seven patients with Stage C and D heart failure with reduced ejection fraction (HFrEF) who failed guideline-directed medical therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:20.761148+00:00"}
{"study_id": 32673, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of a plant-based diet on gut microbiota composition and inflammation in Crohn's Disease patients and assess the utility of trnL gene sequencing for monitoring dietary adherence.", "results_summary": "The study found that a plant-based diet increased microbial diversity, boosted key gut-health-associated genera (e.g., Faecalibacterium and Bacteroides), and reduced fecal calprotectin levels, indicating decreased intestinal inflammation. TrnL sequencing proved more accurate than self-reported food diaries in assessing plant residue diversity.", "population_specificity": "Fourteen Crohn's Disease patients.", "effective_dosage": "Not specified (dietary intervention).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:21.701199+00:00"}
{"study_id": 32675, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of a 16-week whole-food plant-based diet (WPBD) on periodontal parameters in patients with increased cardiometabolic risk.", "results_summary": "The WPBD group showed a reduction in periodontal inflamed surface area (PISA) and matrix-metalloproteinase-8 (MMP-8) levels, while the control group saw an increase in PISA. Saliva pH increased only in the WPBD group, but changes within groups were not statistically significant.", "population_specificity": "36 participants with increased cardiometabolic risk from a randomized clinical trial.", "effective_dosage": "Not specified (whole-food plant-based diet).", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:24.487181+00:00"}
{"study_id": 32676, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to examine associations between healthful and unhealthful plant-based dietary patterns and all-cause mortality risk in individuals with chronic kidney disease (CKD).", "results_summary": "Higher adherence to a healthful plant-based diet was associated with a 34% lower mortality risk, while an unhealthful plant-based diet was linked to a 52% higher risk. Specific food groups like wholegrains reduced mortality risk, whereas refined grains and sugar-sweetened beverages increased it.", "population_specificity": "4807 UK Biobank participants with CKD at baseline.", "effective_dosage": "Not specified (dietary patterns assessed via repeated 24-hour dietary assessments).", "study_duration": "10-year follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:25.380435+00:00"}
{"study_id": 32677, "supplement_id": 1454, "safety_score": "75", "efficacy_score": 65, "quality_score": 70, "study_goal": "To investigate the feasibility of a plant-based diet intervention for Crohn's disease patients and assess its impact on disease activity and quality of life.", "results_summary": "The study found a clinically positive trend in symptom improvement (HBI and IBDQ scores) but no statistically significant effects. Adverse effects included decreased protein intake and slight muscle mass reduction.", "population_specificity": "Outpatients with Crohn's disease on biological therapy.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:26.406794+00:00"}
{"study_id": 32678, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether a plant-based diet is associated with improved survival outcomes in patients with metastatic colorectal cancer (CRC).", "results_summary": "The study found that higher adherence to a plant-based diet, particularly one rich in healthful plant foods, was associated with better overall survival and progression-free survival in metastatic CRC patients. No significant association was observed for unhealthful plant-based diets.", "population_specificity": "Patients with metastatic colorectal cancer (n=1284).", "effective_dosage": "Not specified (dietary indices based on food frequency questionnaires).", "study_duration": "Median follow-up of 6.1 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:27.437608+00:00"}
{"study_id": 32680, "supplement_id": 1454, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the impact of plant-based diets on metabolic dysfunction-associated steatotic liver disease (MASLD) and assess their potential benefits and challenges.", "results_summary": "The study found that plant-based diets can improve weight control, metabolic health, and coexisting diseases, but challenges like adherence difficulties and nutritional deficiencies persist.", "population_specificity": "Individuals with metabolic dysfunction-associated steatotic liver disease (MASLD).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:28.142084+00:00"}
{"study_id": 32684, "supplement_id": 1454, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether clinically healthy adult dogs could maintain health on a complete and well-balanced canine plant-based diet (K9PBN) over twelve months compared to a meat-based diet.", "results_summary": "The study found that clinically healthy adult dogs maintained health, as evidenced by physical exams, blood tests, plasma amino acids, serum vitamins, and cardiac biomarkers, when fed commercial K9PBN for twelve months. No adverse health outcomes were reported, suggesting nutritional equivalence to a meat-based diet.", "population_specificity": "Clinically healthy adult dogs living in households in Los Angeles County, California.", "effective_dosage": "Not specified (commercial K9PBN).", "study_duration": "Twelve months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:30.820443+00:00"}
{"study_id": 32679, "supplement_id": 1454, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the safety and feasibility of a plant-based diet (PBD) in hyperkalemic chronic kidney disease (CKD) patients receiving the potassium binder sodium zirconium cyclosilicate (SZC).", "results_summary": "The study found that PBD improved dietary quality and increased healthy food intake while maintaining stable plasma potassium levels within normal ranges for most patients. No episodes of severe hyperkalemia or hypokalemia occurred, and improvements were noted in fiber intake, dietary quality, and some aspects of quality of life.", "population_specificity": "Hyperkalemic patients with CKD stage 4-5 not on dialysis (n=26).", "effective_dosage": "Not specified (weekly food basket for PBD, SZC titrated to achieve normokalemia).", "study_duration": "6 weeks (3 weeks low-protein low-potassium diet + SZC, 3 weeks PBD + SZC).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:30.987901+00:00"}
{"study_id": 32681, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of cholesterol supplementation in a plant-based diet on the intestinal barriers (physical, chemical, immune, and biological) of GIFT strain tilapia.", "results_summary": "The study found that supplementing 1.2% cholesterol in a plant-based diet improved intestinal structure, tight junction function, enzyme activity, reduced inflammation-related gene expression, and enhanced microbiota composition in tilapia. The 1.2% dosage showed the most significant benefits compared to other tested levels.", "population_specificity": "GIFT strain tilapia (Oreochromis niloticus) with an initial mean weight of 6.08 \u00b1 0.12 g.", "effective_dosage": "0.6%, 1.2%, and 1.8% cholesterol added to the plant-based diet.", "study_duration": "9 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:31.321250+00:00"}
{"study_id": 32685, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the association between plant-based diet index (PDI) and COVID-19 severity, specifically whether higher PDI scores correlated with lower hospitalization rates.", "results_summary": "The study found that higher overall PDI and healthy PDI scores were associated with significantly lower odds of hospitalization in COVID-19 patients, suggesting a protective effect. Adjusted odds ratios indicated a 58% and 55% reduction in hospitalization risk per 10-unit increase in overall PDI and healthy PDI, respectively.", "population_specificity": "141 patients with confirmed COVID-19, categorized into severe (hospitalized) and non-severe (treated at home) cases.", "effective_dosage": "Not specified (dietary intake assessed via food frequency questionnaire).", "study_duration": "Not specified (cross-sectional study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:34.266367+00:00"}
{"study_id": 32687, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify barriers adults aged 18 to 65 in high-income countries face when adopting a plant-based diet (PBD) and map these barriers to behavior change strategies.", "results_summary": "The study identified 40 barriers grouped into 11 themes, with nutritional intake/requirements, habits, and lack of knowledge being the most prominent. Education interventions and communication/marketing policies were suggested to address these barriers.", "population_specificity": "Adults aged 18 to 65 living in high-income countries.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:35.184613+00:00"}
{"study_id": 32690, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "To evaluate whether a 12-week learning management system combining nutritional intervention with emotional intelligence education could improve cardiometabolic outcomes in individuals with elevated BMI.", "results_summary": "The study found significant reductions in BMI and LDL levels at program completion and 6-month follow-up, along with improvements in secondary outcomes like energy/fatigue, self-regard, decision-making, and stress management.", "population_specificity": "37 adult volunteers with BMI greater than 25.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:35.343108+00:00"}
{"study_id": 32691, "supplement_id": 1454, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a plant-based diet (PBD) could serve as an effective dietary intervention for inflammatory bowel disease (IBD), countering the negative effects of the current westernized diet.", "results_summary": "The study found that a PBD significantly improved remission rates in both Crohn's disease (96%) and severe ulcerative colitis (76%), with relapse-free outcomes in 52% of Crohn's disease patients at 10-year follow-up. Additionally, PBD alone induced remission in one-third of mild ulcerative colitis cases without medication.", "population_specificity": "Patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, treated on an inpatient basis.", "effective_dosage": "Not specified (dietary intervention without quantified dosage).", "study_duration": "Varied (follow-up periods included 1, 5, and 10 years).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:38.684919+00:00"}
{"study_id": 32693, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of a lifestyle intervention focusing on a healthy plant-based diet on risk markers for obesity and related metabolic conditions.", "results_summary": "The study found significant improvements in dietary quality, body weight, BMI, waist circumference, cholesterol levels, blood pressure, and other metabolic markers after 10 weeks and sustained reductions in weight and LDL cholesterol after 16 months. Increases in adherence to a healthful plant-based diet were associated with these improvements.", "population_specificity": "Mostly middle-aged and elderly participants from the general population (n = 115).", "effective_dosage": "Not specified", "study_duration": "16 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:39.198742+00:00"}
{"study_id": 32694, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether a short-term whole-food plant-based (WFPB) diet could reduce daytime sleepiness in patients with obstructive sleep apnea (OSA).", "results_summary": "The study found a statistically significant mean decrease of 3.8 points on the Epworth Sleepiness Scale (ESS) after switching from a standard Western diet to a WFPB diet, suggesting reduced daytime sleepiness. The results indicate that a WFPB diet may be a viable intervention for this symptom.", "population_specificity": "14 patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:39.793505+00:00"}
{"study_id": 32696, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore hypertension management among Indonesian farmers using a plant-based diet (PBD), assess its acceptability, and evaluate the effectiveness of a community-based nursing program for hypertension treatment.", "results_summary": "The study expects to develop a PBD model for hypertension management, assess its acceptability among farmers, and implement a community-based nursing program. Results indicate potential benefits but require local validation for broader application.", "population_specificity": "Farmers in Indonesia with hypertension.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:41.092067+00:00"}
{"study_id": 32699, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 40, "study_goal": "The researchers aimed to explore the impact of a whole food plant-based diet on managing multiple sclerosis symptoms in patients who stopped disease-modifying therapies.", "results_summary": "Two patients with multiple sclerosis who adopted a whole food plant-based diet experienced only one flare-up each over 5-6 years after discontinuing medication, suggesting potential benefits of dietary intervention.", "population_specificity": "Patients with multiple sclerosis (specifically two case reports).", "effective_dosage": "Not specified", "study_duration": "5-6 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:42.509202+00:00"}
{"study_id": 32697, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the therapeutic effects of a plant-based diet (PBD) in inflammatory bowel disease (IBD) and assess its role as part of a first-line therapy.", "results_summary": "The study reported a 96% remission rate in Crohn's disease (CD) and a relapse-free course in 52% of CD patients when PBD was combined with infliximab. The authors assert that PBD is anti-inflammatory and highly recommended for IBD.", "population_specificity": "Patients with newly developed Crohn's disease (CD) and severe ulcerative colitis (UC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:42.922306+00:00"}
{"study_id": 32698, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the associations between adherence to a plant-based diet and cognitive aging in older adults.", "results_summary": "The study found no significant associations between overall, healthful, or unhealthful plant-based diet adherence and cognitive function or change. However, a potential benefit was observed in individuals with higher fish consumption (\u22650.93 portions/week).", "population_specificity": "Community-dwelling adults aged \u226565 years.", "effective_dosage": "Not specified", "study_duration": "2-year follow-up", "interactions": "Fish consumption influenced the association between plant-based diet adherence and cognitive functioning.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:43.268927+00:00"}
{"study_id": 32702, "supplement_id": 1454, "safety_score": "85", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to determine the influence of a diet change to veganism on the strength performance of strength-trained individuals.", "results_summary": "The study found no difference in absolute and relative strength performance (leg press and bench press) after switching to a vegan diet. Protein intake decreased significantly and was lower than current recommendations for athletes, but total calorie and carbohydrate intake showed only small treatment effects.", "population_specificity": "15 omnivorous, strength-trained individuals (10 completed the study).", "effective_dosage": "Not specified", "study_duration": "16 weeks (8 weeks omnivorous diet, 8 weeks vegan diet).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:47.065260+00:00"}
{"study_id": 32703, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of a Whole Food Plant-based (WFPB) diet in improving weight and biochemical markers of disease in a clinical setting.", "results_summary": "Adoption of a WFPB diet led to significant weight loss (4.3 kg), reduced total cholesterol and triglycerides, and increased HDL levels. The study demonstrated clinically meaningful improvements in metabolic health markers.", "population_specificity": "17 participants (average age 59 years, 59% female) with conditions like hyperlipidemia, hypertension, coronary artery disease, fatty liver disease, and diabetes mellitus.", "effective_dosage": "Not specified", "study_duration": "Median attendance of 3 group sessions (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:49.599702+00:00"}
{"study_id": 32701, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the association between the plant-based diet index (PDI) and type 2 diabetes (T2D) risk in a Chinese population, particularly examining differences based on cardiovascular risk levels.", "results_summary": "Higher PDI scores were associated with significantly reduced T2D risk in the total population, high cardiovascular risk group (HCRP), and non-high cardiovascular risk group (non-HCRP). The protective effect was stronger in subgroups like the elderly, men, and those with lower BMI.", "population_specificity": "50,694 Chinese residents aged 35-75, divided into high cardiovascular risk (HCRP; n=17,255) and non-high cardiovascular risk (non-HCRP; n=33,439) groups.", "effective_dosage": "Not specified (PDI calculated from food frequency questionnaire).", "study_duration": "Not specified (recruitment occurred between 2017-2019).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:49.969582+00:00"}
{"study_id": 32704, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine how different messaging strategies (addition vs. replacement of meat with legumes, with or without dynamic norms) influence short-term and long-term legume and meat consumption in promoting a plant-based diet.", "results_summary": "Addition messages increased legume consumption more than replacement messages in the short term, especially among those with negative evaluations of flexitarians. Long-term legume consumption increased only when addition messages were combined with dynamic norms. Replacement messages reduced meat consumption more effectively in the short term, while replacement messages with dynamic norms were more effective in the long term.", "population_specificity": "428 volunteers (specific demographics not detailed).", "effective_dosage": "Not specified (messaging intervention only).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:50.745333+00:00"}
{"study_id": 32706, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of plant-based diets (PBDs) as a treatment for obesity and their benefits in managing other non-communicable diseases like type 2 diabetes.", "results_summary": "The study found that PBDs can lead to weight loss, improved cardiovascular health, lower blood pressure, and better glucose metabolism, though many RCTs were short-term, and longer-term studies are needed.", "population_specificity": "Obese patients and individuals with non-communicable diseases like type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Short-term (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:51.290870+00:00"}
{"study_id": 32705, "supplement_id": 1454, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to compare the nutrient profiles and cardiovascular health effects of a whole-food plant-based diet (PBD) versus an omnivorous diet in individuals with cardiovascular risk factors.", "results_summary": "The PBD group showed lower energy density, cholesterol, saturated fat, and salt intake, along with higher fiber consumption. It also led to significant improvements in body weight, BMI, waist circumference, HbA1c, and fasting blood glucose compared to the control group, though vitamin B12 deficiency was noted in the PBD group.", "population_specificity": "Individuals with cardiovascular risk factors (n = 36 in PBD group, n = 34 in control group).", "effective_dosage": "Not specified (dietary intervention included eight 90-minute group meetings and two 120-minute cooking sessions).", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:52.934994+00:00"}
{"study_id": 32707, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if combining infliximab and a plant-based diet as first-line therapy could improve long-term relapse-free rates in patients with Crohn's disease.", "results_summary": "The study found that infliximab and a plant-based diet resulted in relapse-free rates of 79%, 66%, 57%, and 52% at 1, 2, 3, and 4 years, respectively, with no further reduction up to 10 years. The plant-based diet score significantly improved over time, and surgical rates remained relatively low (12% at 5 years, 19% at 10 years).", "population_specificity": "Newly diagnosed adult patients with Crohn's disease in Japan.", "effective_dosage": "Not specified (plant-based diet only, no dosage mentioned).", "study_duration": "Median follow-up period was 8.6 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:53.843313+00:00"}
{"study_id": 32708, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of a plant-based diet (PBD) versus a traditional diet (TD) on plasma levels of TMAO and its precursors (choline and betaine) in healthy adult dogs.", "results_summary": "The study found that dogs consuming a PBD had significantly lower plasma choline and betaine levels compared to those on a TD, but no difference in plasma TMAO levels was detected. The PBD had lower betaine content than the TD, while choline content was similar in both diets.", "population_specificity": "Sixteen healthy adult mixed breed dogs from a university colony.", "effective_dosage": "Not specified (commercial extruded diets).", "study_duration": "4 weeks per diet.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:56.200591+00:00"}
{"study_id": 32710, "supplement_id": 1454, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether adding whole eggs to a plant-based diet (PBD) would protect against oxidative stress and low-grade inflammation in individuals with metabolic syndrome (MetS).", "results_summary": "The study found that adding eggs to a PBD did not negatively affect inflammation or oxidative stress and may provide additional protection against MetS biomarkers, such as reducing plasma malondialdehyde (MDA) concentrations. Eggs were also more effective than egg substitutes in reversing MetS characteristics.", "population_specificity": "24 men and women with metabolic syndrome (MetS).", "effective_dosage": "Two whole eggs with 70 g of spinach/day (EGG) or equivalent egg substitute with spinach (SUB) as breakfast.", "study_duration": "4 weeks per intervention (with a 3-week washout between interventions).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:06:59.951548+00:00"}
{"study_id": 32709, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to systematically review the effects of plant-based diets on prostate cancer risk, oncologic outcomes, and general health/nutrition in at-risk men and patients with prostate cancer.", "results_summary": "Interventional studies showed improvements in short-term oncologic outcomes and general health, while observational studies indicated either protective or null associations between plant-based diets and prostate cancer risk, with vegan diets consistently showing favorable results.", "population_specificity": "Men at risk for prostate cancer, patients with prostate cancer (including those on active surveillance or with biochemical recurrence), and caregivers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:08.330888+00:00"}
{"study_id": 32688, "supplement_id": 1454, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the relationship between plant-based diet indices postdiagnosis and quality-of-life domains in individuals with nonmetastatic prostate cancer.", "results_summary": "A higher plant-based diet index was associated with better scores in sexual function, urinary irritation/obstruction, urinary incontinence, and hormonal/vitality. Healthful plant-based foods also showed associations with improved sexual and bowel function, urinary incontinence, and hormonal/vitality in age-adjusted analysis, though not in multivariable analysis.", "population_specificity": "3,505 male participants with nonmetastatic prostate cancer from the Health Professionals Follow-Up Study (1986\u20132016).", "effective_dosage": "Not specified", "study_duration": "Median time from diagnosis/treatment to first quality-of-life questionnaire was 7.0 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:19.704941+00:00"}
{"study_id": 35289, "supplement_id": 1508, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of foot reflexology on pain and nausea among inpatients with cancer compared to traditional nursing care alone.", "results_summary": "Foot reflexology significantly decreased pain in cancer inpatients compared to traditional care, while effects on nausea were not statistically significant but showed some clinical relevance.", "population_specificity": "Adult cancer patients hospitalized on a 24-bed inpatient oncology unit.", "effective_dosage": "20-25 minute treatment session.", "study_duration": "Single session (20-25 minutes).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:27.750348+00:00"}
{"study_id": 35285, "supplement_id": 1508, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of foot and palm reflexology on respiratory distress in preterm infants receiving noninvasive ventilation.", "results_summary": "Reflexology massage, particularly palm reflexology, significantly improved oxygen saturation, respiratory rate, and respiratory distress scores in preterm infants compared to the control group. The effects were statistically significant after three days of intervention.", "population_specificity": "Preterm infants hospitalized in intensive care units with respiratory distress.", "effective_dosage": "10-minute reflexology massage sessions, performed 6 times over 3 days.", "study_duration": "3 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:27.959235+00:00"}
{"study_id": 35284, "supplement_id": 1508, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether reflexology could reduce headache and muscle pain intensity in patients receiving electroconvulsive therapy (ECT).", "results_summary": "Reflexology significantly reduced the severity of headache and muscle pain in the intervention group compared to the control group, with notable differences observed at multiple time points post-intervention. The study concluded that reflexology is effective for pain reduction in ECT patients.", "population_specificity": "56 patients with depression receiving ECT in a teaching hospital in Iran.", "effective_dosage": "20 minutes of reflexology at reflex points.", "study_duration": "Single session (20 minutes).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:28.091141+00:00"}
{"study_id": 35291, "supplement_id": 1508, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of foot reflexology on ankle brachial index, diabetic peripheral neuropathy, and glycemic control in older adults with diabetes.", "results_summary": "Foot reflexology significantly improved diabetic peripheral neuropathy and glycemic control (reduced glycated hemoglobin A levels) in the experimental group compared to the control group, but had no significant effect on ankle brachial index. The effect sizes were medium for both outcomes.", "population_specificity": "Older adults (aged 65+) with diabetes in Turkey.", "effective_dosage": "Not specified (foot reflexology performed for 12 weeks).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:28.141622+00:00"}
{"study_id": 35287, "supplement_id": 1508, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "To determine the effect of foot reflexology on the sexual function of hemodialysis patients.", "results_summary": "Foot reflexology significantly improved male orgasm function, sexual desire, and intercourse satisfaction in hemodialysis patients compared to sham massage, but no significant effects were observed for erectile function, overall satisfaction, or female sexual function.", "population_specificity": "47 chronic hemodialysis patients (43 males, 5 females) referred to Imam Reza Hospital in Sirjan, Iran.", "effective_dosage": "30 minutes per session (15 minutes per foot), three times a week for four weeks.", "study_duration": "Four weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:28.204085+00:00"}
{"study_id": 35288, "supplement_id": 1508, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of reflexology and aromatherapy massage on the severity of restless legs syndrome (RLS) in female hemodialysis patients.", "results_summary": "Reflexology did not appear to cause any significant reduction in RLS severity, while aromatherapy massage showed a reduction. The study concluded that aromatherapy massage, not reflexology, should be incorporated into routine care for these patients.", "population_specificity": "105 female patients undergoing hemodialysis in an urban Iranian hospital.", "effective_dosage": "24 sessions (frequency not specified)", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:28.292973+00:00"}
{"study_id": 35286, "supplement_id": 1508, "safety_score": "100", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the benefits of foot reflexology as a complementary therapy for managing acute chemotherapy-induced nausea and vomiting (CINV) in patients with digestive or lung cancer.", "results_summary": "Foot reflexology significantly improved acute nausea severity and reduced antiemetic drug consumption, though it showed no significant impact on delayed nausea, vomiting, quality of life, or anxiety. No adverse effects were reported.", "population_specificity": "Patients with lung or digestive cancer undergoing platinum-based chemotherapy.", "effective_dosage": "30-minute foot reflexology sessions per chemotherapy cycle.", "study_duration": "Conducted between April 2018 and April 2020 (exact per-patient duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:28.744597+00:00"}
{"study_id": 35290, "supplement_id": 1508, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of reflexology and meditative practices in managing fatigue and other symptoms in cancer patients and their caregivers, evaluating different sequencing strategies.", "results_summary": "The study found no significant differences among the four decision rules for symptom management, except for lower symptom severity at week 8 when using reflexology alone compared to sequencing reflexology with meditative practices. Adding the other therapy for nonresponders after 4 weeks did not show additional benefits.", "population_specificity": "Patients with cancer and their informal caregivers.", "effective_dosage": "Not specified (intervention duration was 4-8 weeks).", "study_duration": "12 weeks (initial 4-week intervention, with possible extension to 8 weeks for nonresponders).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:30.711497+00:00"}
{"study_id": 35297, "supplement_id": 1508, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "To determine if adding aromatherapy and foot reflexology to standard care improves pain and anxiety in cervical cancer patients undergoing brachytherapy.", "results_summary": "The intervention group showed equal or lower average pain and anxiety scores at all time points, with statistically significant reductions in anxiety post-reflexology.", "population_specificity": "41 women with locally advanced cervical cancer receiving intracavitary brachytherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:35.902412+00:00"}
{"study_id": 35295, "supplement_id": 1508, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to examine the efficacy of foot reflexology for reducing symptoms of infantile colic, including crying duration and colic severity.", "results_summary": "The study found that foot reflexology significantly reduced Infant Colic Scale scores and daily crying duration compared to placebo, with infants in the reflexology group crying less and experiencing fewer symptoms post-treatment.", "population_specificity": "45 infants diagnosed with infantile colic (20 in the reflexology group, 25 in the placebo group).", "effective_dosage": "Four 20-minute sessions over two weeks.", "study_duration": "Two weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:35.911172+00:00"}
{"study_id": 35294, "supplement_id": 1508, "safety_score": "90", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of foot reflexology massage on the incidence of delirium and sleep quality in patients undergoing cardiac surgery.", "results_summary": "Foot reflexology did not significantly reduce delirium or improve sleep quality, but it did decrease pain intensity in postoperative cardiac surgery patients. The odds ratio for delirium reduction was not statistically significant, and sleep quality differences between groups were negligible.", "population_specificity": "60 patients undergoing CABG surgery, randomized into intervention and control groups.", "effective_dosage": "15 minutes per foot, for two consecutive days.", "study_duration": "2 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:36.043190+00:00"}
{"study_id": 35296, "supplement_id": 1508, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the feasibility of a larger trial to determine the effect of foot reflexology on patients undergoing hospital-based haemodialysis, focusing on HRQOL and sleep quality.", "results_summary": "The study found statistically significant improvements in both physical and mental health components of HRQOL and sleep quality post-intervention, with positive patient reception and no disruption to haemodialysis routines.", "population_specificity": "Twenty patients undergoing hospital-based haemodialysis treatment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:36.374746+00:00"}
{"study_id": 35293, "supplement_id": 1508, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of foot reflexology massage on pruritus in hemodialysis patients.", "results_summary": "Foot reflexology massage significantly reduced itching or pruritus in hemodialysis patients (P < 0.001), with no significant difference in pruritus scores between groups before the intervention (P = 0.59). The control group also showed statistically significant changes in pruritus scores (P < 0.001).", "population_specificity": "Hemodialysis patients with moderate-to-severe pruritus.", "effective_dosage": "Nine sessions of foot reflexology massage (3 days a week for 20 min per session, 10 min on each foot).", "study_duration": "3 weeks (9 sessions total).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:37.118326+00:00"}
{"study_id": 35292, "supplement_id": 1508, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of reflexology based on Watson's theory of human caring on anxiety, depression, and quality of life in gynecological cancer patients.", "results_summary": "Reflexology significantly reduced anxiety and depression levels and improved quality of life in gynecological cancer patients. It also alleviated chemotherapy-related symptoms like fatigue, pain, insomnia, and loss of appetite, though some symptoms (nausea, vomiting, diarrhea, constipation) temporarily worsened two weeks post-intervention.", "population_specificity": "Gynecological cancer patients undergoing chemotherapy.", "effective_dosage": "Not specified", "study_duration": "October 2016 to June 2018 (exact intervention duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:37.386495+00:00"}
{"study_id": 35298, "supplement_id": 1508, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether foot reflexology could effectively manage amnesia in patients undergoing electroconvulsive therapy (ECT).", "results_summary": "The study found that foot reflexology significantly improved recalling scores in the intervention group compared to the control group, suggesting it may be effective in managing post-ECT amnesia. The technique was described as simple, inexpensive, and non-invasive with few side effects.", "population_specificity": "68 patients undergoing ECT who met the inclusion criteria.", "effective_dosage": "20 minutes of foot reflexology per day.", "study_duration": "3 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:07:38.426995+00:00"}
